Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2008);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Region;Publisher;Coverage;Categories
1;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;11.171;Q1;210;23;70;3175;1681;70;23.63;138.04;United States;Northern America;Annual Reviews Inc.;1965-1973, 1975-2021;"Pharmacology (Q1); Toxicology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;10.461;Q1;241;18;83;7023;1886;79;21.53;390.17;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1949, 1951-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;20425;Nature Reviews Drug Discovery;journal;14741784, 14741776;7.292;Q1;348;165;659;8590;5717;345;12.08;52.06;United Kingdom;Western Europe;Nature Publishing Group;2002-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
4;22321;Trends in Pharmacological Sciences;journal;18733735, 01656147;4.697;Q1;225;88;301;5411;2887;282;9.81;61.49;United Kingdom;Western Europe;Elsevier Ltd.;1979-2021;"Pharmacology (Q1); Toxicology (Q1)"
5;21195;Pharmacology and Therapeutics;journal;1879016X, 01637258;4.252;Q1;211;94;330;16214;3339;327;10.46;172.49;United States;Northern America;Elsevier Inc.;1975-1977, 1979-1985, 1987-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
6;24032;Reviews of Physiology Biochemistry and Pharmacology;journal;16175786, 03034240;3.78;Q1;66;5;25;733;150;25;6.47;146.6;Germany;Western Europe;Springer Verlag;1974-2008, 2012-2018;"Biochemistry (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Physiology (Q1); Physiology (medical) (Q1)"
7;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;3.544;Q1;233;311;805;31655;4907;800;5.87;101.78;Switzerland;Western Europe;Birkhauser Verlag Basel;1952, 1997-2021;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
8;18017;Neuropsychopharmacology;journal;0893133X, 1470634X;3.385;Q1;227;304;770;19392;5121;742;6.35;63.79;United Kingdom;Western Europe;Nature Publishing Group;1987-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
9;4700152457;Nano Today;journal;17480132;3.37;Q1;155;21;67;977;319;40;4.76;46.52;Netherlands;Western Europe;Elsevier;1970, 2006-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
10;19409;Advanced Drug Delivery Reviews;journal;0169409X, 18728294;3.144;Q1;331;140;369;14876;3479;310;8.24;106.26;Netherlands;Western Europe;Elsevier;1987-2021;Pharmaceutical Science (Q1)
11;18148;Pain;journal;18726623, 03043959;3.03;Q1;269;429;965;17094;5895;770;5.15;39.85;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1975-2021;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
12;20681;Current Opinion in Pharmacology;journal;14714973, 14714892;3.008;Q1;139;109;296;5522;1986;264;6.61;50.66;Netherlands;Western Europe;Elsevier BV;2001-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
13;26371;Natural Product Reports;journal;02650568, 14604752;2.918;Q1;188;58;167;8919;1104;162;6.39;153.78;United Kingdom;Western Europe;Royal Society of Chemistry;1984-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
14;12455;Molecular Therapy;journal;15250024, 15250016;2.837;Q1;185;266;753;10428;4301;690;5.66;39.2;United States;Northern America;Cell Press;2000-2021;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
15;12611;Drug Resistance Updates;journal;13687646, 15322084;2.826;Q1;119;16;65;2260;533;63;9.33;141.25;United States;Northern America;Churchill Livingstone;1998-2021;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
16;19963;Molecular Pharmacology;journal;15210111, 0026895X;2.548;Q1;202;358;1248;14190;6224;1243;4.89;39.64;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1965-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
17;21100456838;Cell Chemical Biology;journal;24519448, 24519456;2.52;Q1;190;161;502;5665;2198;464;4.25;35.19;United States;Northern America;Elsevier Inc.;2016-2021;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
18;19907;Medicinal Research Reviews;journal;01986325, 10981128;2.488;Q1;134;31;83;5055;673;83;8.8;163.06;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
19;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.45;Q1;269;734;2360;22678;11564;2239;4.92;30.9;United States;Northern America;American Society for Microbiology;1963-1970, 1972-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
20;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.379;Q1;146;137;375;6799;1824;353;4.27;49.63;Germany;Western Europe;Springer Verlag;1976-1978, 1980-1981, 1995-2021;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
21;29311;Current Cancer Drug Targets;journal;15680096, 18735576;2.308;Q1;96;71;172;7181;852;165;4.54;101.14;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Cancer Research (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
22;21000196010;Topics in antiviral medicine;journal;21615861, 21615853;2.302;Q1;43;19;63;220;323;62;5.41;11.58;United States;Northern America;International Antiviral Society;2011-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q1)"
23;21782;Psychopharmacology;journal;00333158, 14322072;2.275;Q1;202;337;1187;19946;5587;1147;4.67;59.19;Germany;Western Europe;Springer Verlag;1959-2021;Pharmacology (Q1)
24;23010;Journal of Controlled Release;journal;18734995, 01683659;2.272;Q1;282;274;1054;11328;5704;1045;5.19;41.34;Netherlands;Western Europe;Elsevier;1984-2021;Pharmaceutical Science (Q1)
25;4400151524;Particle and Fibre Toxicology;journal;17438977;2.227;Q1;105;22;38;762;324;38;6.33;34.64;United Kingdom;Western Europe;BioMed Central Ltd.;2004-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
26;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2.203;Q1;276;867;2460;37634;13108;2456;5.01;43.41;United States;Northern America;American Chemical Society;1959-1961, 1963-2021;"Drug Discovery (Q1); Molecular Medicine (Q1)"
27;16876;Bioconjugate Chemistry;journal;15204812, 10431802;2.186;Q1;177;325;699;12419;3480;696;4.81;38.21;United States;Northern America;American Chemical Society;1990-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
28;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;2.186;Q1;90;50;163;7211;820;145;4.88;144.22;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Neuroscience (miscellaneous) (Q1); Pharmacology (Q1)"
29;20626;Clinical Pharmacology and Therapeutics;journal;15326535, 00099236;2.176;Q1;195;278;538;6909;3500;461;6.17;24.85;United States;Northern America;Wiley-Blackwell;1960-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
30;110112;Journal of Immunotherapy;journal;15249557, 15374513;2.166;Q1;97;97;220;3527;995;216;4.15;36.36;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1991-2021;"Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Pharmacology (Q1)"
31;5100155080;Neurotherapeutics;journal;19337213;2.162;Q1;122;65;191;5266;1119;175;4.59;81.02;United States;Northern America;Springer New York;2007-2021;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
32;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;2.095;Q1;117;44;97;5208;684;91;7.16;118.36;United Kingdom;Western Europe;Informa Healthcare;1971-2021;Toxicology (Q1)
33;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;2.081;Q1;115;131;507;6590;2042;503;4.17;50.31;Netherlands;Western Europe;Springer Netherlands;1996-2021;"Biochemistry (medical) (Q1); Cancer Research (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cell Biology (Q2)"
34;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;2.076;Q1;203;563;1439;13976;5963;1174;3.98;24.82;United Kingdom;Western Europe;Oxford University Press;1975-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
35;21196;Drug Discovery Today;journal;18785832, 13596446;2.001;Q1;185;150;629;8163;3089;570;5.57;54.42;United Kingdom;Western Europe;Elsevier Ltd.;1996-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
36;23916;Environmental Pollution;journal;02697491, 18736424;1.922;Q1;249;531;1225;22527;4580;1208;3.46;42.42;United Kingdom;Western Europe;Elsevier Ltd.;1970-1980, 1986-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
37;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.911;Q1;90;49;142;2125;882;140;5.72;43.37;United Kingdom;Western Europe;Nature Publishing Group;2001-2021;"Genetics (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
38;23488;Current Medicinal Chemistry;journal;09298673, 1875533X;1.9;Q1;183;257;694;34995;3898;687;5.3;136.17;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1994-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
39;26380;Drug and Alcohol Dependence;journal;03768716;1.874;Q1;173;250;635;11420;2548;618;3.69;45.68;Ireland;Western Europe;Elsevier Ireland Ltd;1975-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
40;20084;British Journal of Pharmacology;journal;14765381, 00071188;1.856;Q1;223;530;1188;30735;5395;1169;4.75;57.99;United States;Northern America;Wiley-Blackwell;1965-2021;Pharmacology (Q1)
41;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.855;Q1;233;472;1838;18103;8493;1827;4.6;38.35;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1945-2021;"Molecular Medicine (Q1); Pharmacology (Q1)"
42;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.843;Q1;113;109;258;5846;1060;226;3.85;53.63;United Kingdom;Western Europe;Oxford University Press;1998-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
43;20435;Neuropharmacology;journal;00283908, 18737064;1.797;Q1;176;296;754;16460;2872;752;3.64;55.61;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;"Pharmacology (Q1); Cellular and Molecular Neuroscience (Q2)"
44;20063;Biochemical Pharmacology;journal;18732968, 00062952;1.768;Q1;206;379;1092;22316;5135;1029;5.11;58.88;United States;Northern America;Elsevier Inc.;1958-2021;"Biochemistry (Q1); Pharmacology (Q1)"
45;25218;Toxicological Sciences;journal;10960929, 10966080;1.752;Q1;193;260;970;12280;4497;937;4.76;47.23;United Kingdom;Western Europe;Oxford University Press;1981-2021;Toxicology (Q1)
46;24749;Addiction Biology;journal;13556215, 13691600;1.72;Q1;83;47;115;2938;451;107;4.67;62.51;United States;Northern America;Wiley-Blackwell;1996-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
47;12331;Current Topics in Medicinal Chemistry;journal;15680266, 18734294;1.705;Q1;122;164;473;11874;1957;410;3.99;72.4;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
48;4000148203;Handbook of Experimental Pharmacology;journal;01712004;1.701;Q1;96;122;424;12459;1156;411;2.73;102.12;Germany;Western Europe;Springer Heidelberg;2004-2021;"Biochemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
49;21790;Antiviral Therapy;journal;20402058, 13596535;1.698;Q1;89;143;402;4971;1551;395;3.65;34.76;United Kingdom;Western Europe;International Medical Press Ltd;1996-2021;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
50;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;1.659;Q1;100;83;146;8934;734;138;4.48;107.64;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Molecular Medicine (Q1); Pharmacology (Q1); Cancer Research (Q2)"
51;20682;Current Pharmaceutical Design;journal;13816128, 18734286;1.642;Q1;166;370;1041;42030;4611;928;4.44;113.59;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1995-2021;"Drug Discovery (Q1); Pharmacology (Q1)"
52;20758;Current Drug Targets: Inflammation and Allergy;journal;1568010X;1.632;Q1;51;0;88;0;423;79;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2002-2005;"Immunology and Allergy (Q1); Pharmacology (Q1); Immunology (Q2)"
53;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.629;Q1;159;242;801;12002;2754;792;3.25;49.6;United States;Northern America;Wiley-Blackwell;1977-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
54;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.628;Q1;96;64;210;2252;558;201;2.26;35.19;United Kingdom;Western Europe;Nature Publishing Group;2006-2021;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
55;20664;Current Drug Targets;journal;18735592, 13894501;1.622;Q1;107;129;390;11694;1674;349;4.36;90.65;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
56;26512;Tetrahedron;journal;14645416, 00404020;1.605;Q1;226;1322;3871;66367;12351;3841;3.06;50.2;United Kingdom;Western Europe;Elsevier Ltd.;1957-2021;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
57;130044;Pharmacogenetics and Genomics;journal;17446880, 17446872;1.598;-;144;120;317;4488;1682;315;4.64;37.4;United States;Northern America;Lippincott Williams and Wilkins Ltd.;2005-2021;"Genetics (clinical) (Q1); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
58;22072;Current Gene Therapy;journal;18755631, 15665232;1.597;Q1;75;41;146;4914;697;142;4.41;119.85;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
59;12584;Drug Metabolism Reviews;journal;10979883, 03602532;1.561;Q1;100;24;110;2299;576;106;4.99;95.79;United States;Northern America;Informa Healthcare;1972-2021;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
60;130126;Molecular Pharmaceutics;journal;15438384, 15438392;1.556;Q1;138;111;240;5512;1153;226;4.56;49.66;United States;Northern America;American Chemical Society;2004-2021;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2)"
61;20104;CNS Drug Reviews;journal;1080563X, 15273458;1.552;Q1;61;0;71;0;327;71;5.16;0;United States;Northern America;Neva Press, Inc.;1995-2007;"Neuropsychology and Physiological Psychology (Q1); Pharmacology (Q1)"
62;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.544;Q1;129;109;349;4615;942;334;2.55;42.34;United States;Northern America;Alcohol Research Documentation, Inc.;2007-2021;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
63;21354;Expert Opinion on Therapeutic Targets;journal;14728222, 17447631;1.533;Q1;94;127;307;12944;1098;285;3.8;101.92;United Kingdom;Western Europe;Taylor and Francis Ltd.;1997-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
64;28792;Cancer Biology and Therapy;journal;15384047, 15558576;1.512;Q1;120;330;1014;12133;2174;728;2.13;36.77;United States;Northern America;Landes Bioscience;2002-2021;"Oncology (Q1); Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2)"
65;15576;European Neuropsychopharmacology;journal;0924977X, 18737862;1.507;Q1;118;117;279;6132;1216;274;3.67;52.41;Netherlands;Western Europe;Elsevier;1990-2021;"Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Biological Psychiatry (Q2)"
66;20624;Clinical Pharmacokinetics;journal;11791926, 03125963;1.48;Q1;169;62;236;4132;1330;224;4.87;66.65;United Kingdom;Western Europe;Adis International Ltd;1976-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
67;23109;Journal of Psychopharmacology;journal;14617285, 02698811;1.428;Q1;121;142;372;6060;1393;323;3.5;42.68;United Kingdom;Western Europe;SAGE Publications Ltd;1987-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
68;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.41;Q1;213;299;750;12904;3171;740;4.38;43.16;United States;Northern America;Springer New York;1984-2021;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Molecular Medicine (Q2)"
69;16088;Journal of Nanobiotechnology;journal;14773155;1.4;Q1;84;14;34;457;165;32;4.12;32.64;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2021;"Applied Microbiology and Biotechnology (Q1); Bioengineering (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
70;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.395;Q1;182;318;841;10714;3764;833;4.22;33.69;United States;Northern America;American Society for Pharmacology and Experimental Therapeutics;1973-2021;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
71;20677;Current Opinion in Drug Discovery and Development;journal;13676733;1.394;Q1;81;74;214;4597;873;196;4.33;62.12;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
72;144771;Clinical Trials;journal;17407753, 17407745;1.377;Q1;67;64;177;1547;339;160;1.57;24.17;United Kingdom;Western Europe;SAGE Publications Ltd;2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
73;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.365;Q1;163;263;664;14791;2605;652;3.71;56.24;United States;Northern America;American Chemical Society;1988-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
74;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;18784216, 02785846;1.351;Q1;134;348;665;14966;2221;607;2.87;43.01;United States;Northern America;Elsevier Inc.;1982-2022;"Pharmacology (Q1); Biological Psychiatry (Q2)"
75;21455;Progress in Medicinal Chemistry;journal;00796468, 18757863;1.35;Q1;36;8;21;1130;65;18;2.08;141.25;Netherlands;Western Europe;Elsevier;1961-1963, 1965, 1967, 1969-2021;"Pharmacology (Q1); Molecular Medicine (Q2)"
76;26514;Tetrahedron Letters;journal;00404039, 18733581;1.346;Q1;173;1772;5878;57000;16252;5877;2.72;32.17;United Kingdom;Western Europe;Elsevier Ltd.;1959-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
77;23053;Journal of Natural Products;journal;01633864, 15206025;1.343;Q1;147;427;1186;11043;3471;1181;3.02;25.86;United States;Northern America;American Chemical Society;1949, 1971, 1973, 1978-2021;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
78;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;18733441, 09396411;1.323;Q1;168;328;459;11602;1837;453;3.79;35.37;Netherlands;Western Europe;Elsevier;1991-2021;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
79;22477;Investigational New Drugs;journal;01676997, 15730646;1.323;Q1;90;68;202;1974;787;199;3.78;29.03;Netherlands;Western Europe;Kluwer Academic Publishers;1983-2021;"Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
80;21197;Pharmacology Biochemistry and Behavior;journal;00913057, 18735177;1.322;Q1;139;255;707;13771;2219;706;2.96;54;United States;Northern America;Elsevier Inc.;1973-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1); Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Biological Psychiatry (Q2)"
81;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.318;Q1;175;366;920;17711;3646;902;3.59;48.39;United States;Northern America;Academic Press Inc.;1959-2021;"Pharmacology (Q1); Toxicology (Q1)"
82;20129;Cardiovascular Drug Reviews;journal;15273466, 08975957;1.317;Q1;50;0;70;0;270;68;4.46;0;United States;Northern America;Neva Press, Inc.;1983-2007;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1)"
83;4000148019;AAPS Journal;journal;15507416;1.291;Q1;118;67;214;2919;994;208;5.15;43.57;United States;Northern America;Springer New York;1999-2021;Pharmaceutical Science (Q1)
84;145164;Human Genomics;journal;14739542, 14797364;1.272;Q1;59;10;55;137;142;43;1.88;13.7;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2006, 2008-2021;"Drug Discovery (Q1); Genetics (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
85;21165;PharmacoEconomics;journal;11707690, 11792027;1.257;Q1;104;84;331;3622;957;279;2.49;43.12;United Kingdom;Western Europe;Adis International Ltd;1992-2021;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
86;21351;Expert Opinion on Investigational Drugs;journal;13543784, 17447658;1.249;Q1;109;173;445;12481;1731;418;3.95;72.14;United Kingdom;Western Europe;Taylor and Francis Ltd.;1994-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
87;20049;Behavioural Pharmacology;journal;14735849, 09558810;1.247;Q1;83;84;235;4587;668;232;2.65;54.61;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1992-2021;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
88;22454;International Journal of Pharmaceutics;journal;18733476, 03785173;1.227;Q1;229;655;1509;21603;5385;1496;3.37;32.98;Netherlands;Western Europe;Elsevier;1978-2021;Pharmaceutical Science (Q1)
89;21237;Drug Safety;journal;01145916, 11791942;1.221;Q1;131;104;287;4704;1097;249;3.38;45.23;United Kingdom;Western Europe;Adis International Ltd;1990-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
90;29712;Clinical Therapeutics;journal;1879114X, 01492918;1.213;Q1;140;273;685;8134;2524;619;3.45;29.79;United States;Northern America;Elsevier Inc.;1977-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
91;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;1.206;Q1;171;995;2207;36669;7129;2204;3.22;36.85;United Kingdom;Western Europe;Elsevier Ltd.;1993-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Molecular Biology (Q2); Molecular Medicine (Q2)"
92;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.204;Q1;89;28;53;5091;240;50;3.8;181.82;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
93;13250;Expert Opinion on Biological Therapy;journal;14712598, 17447682;1.198;Q1;91;171;423;14412;1402;421;3.75;84.28;United Kingdom;Western Europe;Taylor and Francis Ltd.;2001-2021;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
94;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863, 2162660X;1.195;Q1;76;13;37;2583;139;37;3.62;198.69;United States;Northern America;Begell House Inc.;1984-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
95;19617;Antiviral Research;journal;01663542, 18729096;1.194;Q1;134;137;307;6455;1161;305;3.64;47.12;Netherlands;Western Europe;Elsevier;1959, 1981-2021;"Pharmacology (Q1); Virology (Q2)"
96;21169;Pharmacological Research;journal;10436618, 10961186;1.191;Q1;147;115;412;6338;1526;406;3.76;55.11;United States;Northern America;Academic Press Inc.;1989-2021;Pharmacology (Q1)
97;20663;Current Drug Metabolism;journal;18755453, 13892002;1.182;Q1;111;114;183;11387;972;177;4.85;99.89;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Clinical Biochemistry (Q1); Pharmacology (Q1)"
98;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;1.177;Q1;76;35;202;1844;539;200;2.55;52.69;United States;Northern America;Elsevier Inc.;1996, 1998-2021;"Pharmacology (Q1); Biochemistry (Q2); Cell Biology (Q2); Physiology (Q2)"
99;23155;Current Vascular Pharmacology;journal;15701611, 18756212;1.168;Q1;63;39;112;4021;434;106;3.83;103.1;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2003-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q1)"
100;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;1.162;Q1;115;152;429;6337;897;429;2;41.69;United States;Northern America;Springer New York;1973-2021;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
101;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;1.158;Q1;71;63;180;2660;432;151;2.34;42.22;Netherlands;Western Europe;Kluwer Academic Publishers;1987-2021;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
102;14144;Experimental and Clinical Psychopharmacology;journal;19362293, 10641297;1.157;Q1;95;56;149;3445;355;148;2.48;61.52;United States;Northern America;American Psychological Association;1993-2021;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
103;25075;Ecotoxicology;journal;09639292, 15733017;1.152;Q1;97;85;194;3984;495;192;2.48;46.87;Netherlands;Western Europe;Springer Netherlands;1992-2021;"Health, Toxicology and Mutagenesis (Q1); Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
104;18922;Journal of Gene Medicine;journal;1099498X, 15212254;1.152;Q1;94;121;385;4921;1415;385;3.48;40.67;United States;Northern America;John Wiley and Sons Ltd;1998-2021;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
105;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;1.14;Q1;154;1311;3612;33219;10137;3612;2.74;25.34;United Kingdom;Western Europe;Elsevier Ltd.;1991-2021;"Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
106;18071;Neurotoxicity Research;journal;14763524, 10298428;1.136;Q1;78;54;153;4240;496;152;3.24;78.52;United States;Northern America;Springer New York;1999, 2001-2021;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
107;20679;Current Opinion in Investigational Drugs;journal;20403429, 14724472;1.135;Q1;79;126;393;8936;1203;361;3.51;70.92;United Kingdom;Western Europe;Current Drugs Ltd.;2000-2010;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
108;18966;Mutagenesis;journal;02678357, 14643804;1.133;Q1;95;61;171;3497;527;165;3.06;57.33;United Kingdom;Western Europe;Oxford University Press;1986-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Genetics (Q2); Genetics (clinical) (Q2)"
109;19427;Advances in Pharmacology;journal;15578925, 10543589;1.129;Q1;78;17;76;2561;187;70;2.88;150.65;United States;Northern America;Academic Press Inc.;1962-1964, 1966-1973, 1975, 1977-1982, 1984, 1990-2000, 2004-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
110;20051;BioDrugs;journal;11738804, 1179190X;1.121;Q1;71;38;123;3093;411;117;2.91;81.39;United Kingdom;Western Europe;Adis International Ltd;1997-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Biotechnology (Q2)"
111;18800156720;Dissolution Technologies;journal;1521298X;1.121;Q1;34;16;73;220;86;40;1.12;13.75;United States;Northern America;Dissolution Technologies Inc;1996-2021;Pharmaceutical Science (Q1)
112;4600151527;Infectious Disorders - Drug Targets;journal;18715265;1.121;Q1;55;34;93;2979;274;86;3.27;87.62;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Microbiology (medical) (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
113;24763;Addictive Behaviors;journal;03064603;1.118;Q1;135;186;711;6134;1700;710;2.16;32.98;United Kingdom;Western Europe;Elsevier Ltd.;1975-2022;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
114;24797;Mini-Reviews in Medicinal Chemistry;journal;18755607, 13895575;1.107;Q1;95;139;354;14230;1186;345;3.32;102.37;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2001-2021;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
115;27823;Alimentary Pharmacology and Therapeutics, Supplement;journal;09530673;1.1;Q1;66;0;67;0;187;63;0;0;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1991, 1993-2005;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
116;22983;Journal of Clinical Pharmacology;journal;15524604, 00912700;1.093;Q2;121;142;463;4481;1746;448;3.54;31.56;United States;Northern America;Wiley-Blackwell;1973-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
117;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;1.085;Q2;51;35;62;3477;155;57;2.5;99.34;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2015;"Medicine (miscellaneous) (Q1); Immunology (Q2); Immunology and Allergy (Q2); Pharmacology (Q2)"
118;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085, 1873264X;1.083;Q1;133;496;1538;13095;4559;1529;2.97;26.4;Netherlands;Western Europe;Elsevier;1983-2022;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Spectroscopy (Q2)"
119;29097;Cancer Chemotherapy and Pharmacology;journal;14320843, 03445704;1.081;Q1;114;268;590;8806;1733;585;2.88;32.86;Germany;Western Europe;Springer Verlag;1978-2021;"Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2); Pharmacology (Q2)"
120;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1.073;Q2;153;288;645;7173;1902;522;2.88;24.91;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
121;20680;Current Opinion in Molecular Therapeutics;journal;14648431;1.069;Q1;66;71;223;4806;590;201;3.02;67.69;United Kingdom;Western Europe;Current Drugs Ltd.;1999-2010;"Drug Discovery (Q1); Genetics (Q2); Molecular Medicine (Q2); Pharmacology (Q2); Genetics (clinical) (Q3); Molecular Biology (Q3)"
122;130025;Current Drug Delivery;journal;15672018;1.055;Q1;65;45;126;2393;416;124;2.94;53.18;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Pharmaceutical Science (Q1)
123;24028;Reproductive Toxicology;journal;08906238, 18731708;1.048;Q1;117;116;365;4756;1117;338;3.13;41;United States;Northern America;Elsevier Inc.;1987-2021;Toxicology (Q1)
124;4400151608;ChemMedChem;journal;18607187, 18607179;1.047;Q1;106;211;452;9072;1242;448;3.18;43;United Kingdom;Western Europe;John Wiley and Sons Ltd;2006-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Molecular Medicine (Q2); Organic Chemistry (Q2)"
125;144956;Drug Metabolism and Pharmacokinetics;journal;13474367;1.045;Q1;69;64;178;1900;592;174;2.98;29.69;Japan;Asiatic Region;Japanese Society for the Study of Xenobiotics;2002-2021;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
126;15581;Current Pharmaceutical Biotechnology;journal;13892010, 18734316;1.044;Q1;88;62;152;4851;406;134;2.62;78.24;Netherlands;Western Europe;Bentham Science Publishers B.V.;2000-2021;"Pharmaceutical Science (Q1); Biotechnology (Q2)"
127;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;1.044;Q2;87;221;545;7147;1477;536;2.75;32.34;Japan;Asiatic Region;Japanese Pharmacological Society;1996-2021;"Molecular Medicine (Q2); Pharmacology (Q2)"
128;4700152612;Current Nanoscience;journal;15734137;1.043;Q1;47;51;74;3269;187;71;2.53;64.1;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Bioengineering (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Biotechnology (Q2); Nanoscience and Nanotechnology (Q2)"
129;16836;BMC Chemical Biology;journal;14726769;1.042;Q1;20;3;8;101;23;8;3.2;33.67;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Drug Discovery (Q1); Molecular Medicine (Q2)"
130;20783;Expert Review of Vaccines;journal;14760584, 17448395;1.038;Q1;91;137;255;10660;703;232;2.81;77.81;United Kingdom;Western Europe;Taylor and Francis Ltd.;2002-2021;"Drug Discovery (Q1); Immunology (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
131;19034;Microbial Drug Resistance;journal;10766294, 19318448;1.038;Q2;72;44;148;1304;276;148;2;29.64;United States;Northern America;Mary Ann Liebert Inc.;1995-2021;"Medicine (miscellaneous) (Q1); Immunology (Q2); Microbiology (Q2); Microbiology (medical) (Q2); Pharmacology (Q2)"
132;5400152706;Nanotoxicology;journal;17435390, 17435404;1.034;Q1;94;25;26;1137;100;25;3.85;45.48;United Kingdom;Western Europe;Informa Healthcare;2007-2021;"Biomedical Engineering (Q1); Toxicology (Q1); Nanoscience and Nanotechnology (Q2)"
133;25789;Bioorganic Chemistry;journal;00452068, 10902120;1.028;Q2;66;43;111;1436;254;109;2.2;33.4;United States;Northern America;Academic Press Inc.;1971-2021;"Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3)"
134;25109;Inhalation Toxicology;journal;08958378, 10917691;1.027;Q1;90;113;336;4423;840;323;2.47;39.14;United Kingdom;Western Europe;Informa Healthcare;1989-2021;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
135;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;1.025;Q1;133;39;123;1599;485;112;4.05;41;United States;Northern America;Elsevier Inc.;2005-2021;"Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Bioengineering (Q2); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
136;23015;Journal of Ethnopharmacology;journal;03788741, 18727573;1.024;Q2;205;414;1343;16251;4048;1329;2.69;39.25;Ireland;Western Europe;Elsevier Ireland Ltd;1979-2022;"Drug Discovery (Q2); Pharmacology (Q2)"
137;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298, 14321912;1.023;Q2;93;131;266;7602;729;257;2.98;58.03;Germany;Western Europe;Springer Verlag;1969-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
138;21331;European Journal of Pharmaceutical Sciences;journal;18790720, 09280987;1.022;Q1;144;128;549;4033;1664;542;3.87;31.51;Netherlands;Western Europe;Elsevier;1993-2021;Pharmaceutical Science (Q1)
139;24786;Alcohol and Alcoholism;journal;07350414, 14643502;1.02;Q1;103;114;303;4114;772;290;2.33;36.09;United Kingdom;Western Europe;Oxford University Press;1965-2021;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
140;25240;Toxicology Letters;journal;03784274, 18793169;1.02;Q1;150;199;604;7755;1964;585;3.23;38.97;Netherlands;Western Europe;Elsevier BV;1977-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
141;21333;European Journal of Pharmacology;journal;00142999, 18790712;1.018;Q2;189;888;2111;40137;6327;2108;3.07;45.2;Netherlands;Western Europe;Elsevier;1967-2021;Pharmacology (Q2)
142;25219;Toxicology;journal;0300483X, 18793185;1.01;Q2;165;277;929;13310;2959;914;3.04;48.05;Ireland;Western Europe;Elsevier Ireland Ltd;1959, 1973-2021;Toxicology (Q2)
143;23014;Journal of Drug Targeting;journal;10292330, 1061186X;1.008;Q1;95;88;214;3354;597;205;2.9;38.11;United Kingdom;Western Europe;Informa Healthcare;1986-1987, 1992-2021;Pharmaceutical Science (Q1)
144;21124;Pharmaceutical Statistics;journal;15391612, 15391604;1.007;Q2;39;29;92;422;97;76;1.2;14.55;United Kingdom;Western Europe;John Wiley and Sons Ltd;2004-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2); Statistics and Probability (Q2)"
145;9000153111;Comparative Biochemistry and Physiology Part - C: Toxicology and Pharmacology;journal;15320456, 18781659;1.004;Q2;113;114;375;5816;1048;374;2.74;51.02;United States;Northern America;Elsevier Inc.;1989, 2000-2022;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Physiology (Q2); Toxicology (Q2); Cell Biology (Q3)"
146;17595;Journal of Biomolecular Screening;journal;10870571, 1552454X;1;Q2;79;95;293;2340;822;291;2.67;24.63;United States;Northern America;SAGE Publications Inc.;1996-2017;"Analytical Chemistry (Q2); Biochemistry (Q2); Biotechnology (Q2); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
147;23079;Journal of Pharmaceutical Sciences;journal;15206017, 00223549;0.995;Q1;186;400;776;19746;2635;726;3.19;49.37;United States;Northern America;"John Wiley &amp; Sons Inc.";1961-2021;Pharmaceutical Science (Q1)
148;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.993;Q2;64;32;111;930;247;106;2.41;29.06;United States;Northern America;Springer New York;1996-1999, 2001-2021;Pharmacology (Q2)
149;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0.992;Q2;104;155;560;6346;1367;549;2.57;40.94;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Cardiology and Cardiovascular Medicine (Q1); Pharmacology (Q2)"
150;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;0.989;Q2;104;82;174;3201;582;171;3.39;39.04;Netherlands;Western Europe;Springer Netherlands;1987-2021;"Computer Science Applications (Q1); Drug Discovery (Q2); Physical and Theoretical Chemistry (Q2)"
151;21167;Pharmacogenomics;journal;14622416, 17448042;0.988;Q2;94;182;375;9640;1235;331;3.39;52.97;United Kingdom;Western Europe;Future Medicine Ltd.;2000-2021;"Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
152;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.986;Q2;51;43;144;5144;453;144;3.41;119.63;United Kingdom;Western Europe;Taylor and Francis Ltd.;2000-2021;"Pharmacology (medical) (Q1); Pharmacology (Q2)"
153;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.973;Q2;96;130;450;4847;1257;448;2.63;37.28;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1990-2021;"Pharmacology (medical) (Q1); Cancer Research (Q2); Oncology (Q2); Pharmacology (Q2)"
154;17464;European Journal of Medicinal Chemistry;journal;02235234, 17683254;0.962;Q2;175;320;489;10604;1503;489;2.87;33.14;France;Western Europe;Elsevier Masson s.r.l.;1974-2021;"Medicine (miscellaneous) (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2)"
155;24652;Chemico-Biological Interactions;journal;00092797;0.961;Q2;128;217;482;8163;1504;477;3.47;37.62;Ireland;Western Europe;Elsevier Ireland Ltd;1969-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
156;18075;Neurotoxicology and Teratology;journal;08920362, 18729738;0.958;Q2;103;48;211;2975;615;204;2.83;61.98;United States;Northern America;Elsevier Inc.;1987-2021;"Toxicology (Q2); Cellular and Molecular Neuroscience (Q3); Developmental Neuroscience (Q3)"
157;22378;Vascular Pharmacology;journal;18793649, 15371891;0.957;Q2;100;53;304;2501;813;295;2.67;47.19;United States;Northern America;Elsevier Inc.;2002-2021;"Pharmacology (Q2); Physiology (Q2); Molecular Medicine (Q3)"
158;18073;NeuroToxicology;journal;18729711, 0161813X;0.955;Q2;122;144;398;7663;1071;375;2.39;53.22;Netherlands;Western Europe;Elsevier;1979-2021;"Neuroscience (miscellaneous) (Q2); Toxicology (Q2)"
159;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;0.952;Q2;88;123;187;10962;745;182;3.61;89.12;United Kingdom;Western Europe;Taylor and Francis Ltd.;2005-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
160;20473;Life Sciences;journal;18790631, 00243205;0.949;Q1;174;284;1729;11951;4984;1727;2.87;42.08;United States;Northern America;Elsevier Inc.;1962-2021;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2)"
161;84948;Expert Opinion on Drug Delivery;journal;17425247;0.942;Q1;116;98;201;9837;641;190;3.29;100.38;United Kingdom;Western Europe;Taylor and Francis Ltd.;2004-2021;Pharmaceutical Science (Q1)
162;22575;Cardiovascular Toxicology;journal;15307905, 15590259;0.938;Q2;56;21;88;937;209;88;2.55;44.62;United States;Northern America;Humana Press;2001-2021;"Cardiology and Cardiovascular Medicine (Q1); Toxicology (Q2); Molecular Biology (Q3)"
163;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;0.938;Q1;143;179;41;7400;116;36;2.83;41.34;United States;Northern America;Public Library of Science;2007-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1); Infectious Diseases (Q2)"
164;16948;Chirality;journal;1520636X, 08990042;0.936;Q2;80;130;333;4840;784;330;2.22;37.23;United States;Northern America;Wiley-Liss Inc.;1989-2021;"Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Spectroscopy (Q2); Catalysis (Q3)"
165;19900192900;Molecular Informatics;journal;18681751, 18681743;0.925;Q2;70;95;280;4182;690;268;2.48;44.02;Germany;Western Europe;"Wiley - VCH Verlag GmbH &amp; CO. KGaA";2010-2021;"Computer Science Applications (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3); Structural Biology (Q3)"
166;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.909;Q2;75;50;214;2051;568;205;2.5;41.02;United States;Northern America;Elsevier Inc.;1992-2002, 2004-2021;"Pharmacology (Q2); Toxicology (Q2)"
167;24785;Alcohol;journal;07418329;0.905;Q2;83;71;189;3280;494;182;2.39;46.2;United States;Northern America;Elsevier Inc.;1984-2021;"Health (social science) (Q1); Medicine (miscellaneous) (Q1); Biochemistry (Q2); Neurology (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3)"
168;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.904;Q2;87;110;421;3959;776;412;1.87;35.99;Canada;Northern America;National Research Council of Canada;1964-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q2); Physiology (medical) (Q2)"
169;22319;Toxicon;journal;18793150, 00410101;0.898;Q2;133;281;696;10016;1981;682;2.74;35.64;United Kingdom;Western Europe;Elsevier Ltd.;1962-2021;Toxicology (Q2)
170;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.886;Q2;107;251;638;9647;1491;628;2.46;38.43;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1974-2021;"Pharmacology (Q2); Physiology (Q2); Physiology (medical) (Q2)"
171;17067;Phytomedicine;journal;09447113, 1618095X;0.884;Q1;127;153;384;4394;1081;369;2.72;28.72;Germany;Western Europe;Urban und Fischer Verlag Jena;1994-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
172;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;0.863;Q2;77;33;86;1506;217;82;2.52;45.64;United States;Northern America;Springer New York;2006-2021;"Immunology and Allergy (Q2); Neuroscience (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3)"
173;20602;Clinical Neuropharmacology;journal;1537162X, 03625664;0.859;Q2;80;58;192;1480;621;174;2.77;25.52;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1982-2021;"Pharmacology (medical) (Q1); Neurology (clinical) (Q2); Pharmacology (Q2)"
174;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;0.852;Q2;114;165;509;5627;1371;454;2.55;34.1;Germany;Western Europe;Springer Verlag;1968-2021;"Medicine (miscellaneous) (Q1); Pharmacology (medical) (Q1); Pharmacology (Q2)"
175;25151;Journal of Toxicology and Environmental Health - Part A: Current Issues;journal;10872620, 15287394;0.831;Q2;92;187;522;6971;1008;514;1.81;37.28;United Kingdom;Western Europe;Taylor and Francis Ltd.;1996-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
176;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.826;Q2;85;246;767;7026;1332;765;1.57;28.56;United States;Northern America;Wiley-Blackwell;1918-2021;"Biochemistry (Q2); Drug Discovery (Q2); Inorganic Chemistry (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Catalysis (Q3)"
177;23039;Journal of Liposome Research;journal;08982104, 15322394;0.817;Q1;53;26;73;1002;161;72;2.28;38.54;United Kingdom;Western Europe;Informa Healthcare;1988-1990, 1992-2021;Pharmaceutical Science (Q1)
178;4400151410;Human Vaccines;journal;15548600, 15548619;0.811;Q1;58;77;137;3025;290;124;2.06;39.29;United States;Northern America;Landes Bioscience;2005-2011;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Immunology (Q3)"
179;14805;Steroids;journal;0039128X, 18785867;0.81;Q2;107;174;369;6981;1000;367;2.67;40.12;United States;Northern America;Elsevier Inc.;1963-2021;"Biochemistry (Q2); Clinical Biochemistry (Q2); Endocrinology (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Biology (Q3)"
180;25125;Journal of Analytical Toxicology;journal;19452403, 01464760;0.802;Q2;78;125;343;2688;669;322;1.72;21.5;United States;Northern America;Preston Publications;1977-2021;"Chemical Health and Safety (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
181;25224;Toxicology in Vitro;journal;18793177, 08872333;0.796;Q2;112;237;510;8995;1470;503;2.83;37.95;United Kingdom;Western Europe;Elsevier Ltd.;1987-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
182;24604;Archives of Toxicology;journal;14320738, 03405761;0.794;Q2;121;103;294;5046;798;289;2.79;48.99;Germany;Western Europe;Springer Verlag;1930-1940, 1943-1944, 1972-2021;"Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
183;25093;Environmental Toxicology;journal;15227278, 15204081;0.792;Q2;81;94;226;3335;501;224;2.01;35.48;United States;Northern America;"John Wiley &amp; Sons Inc.";1980, 1999-2021;"Management, Monitoring, Policy and Law (Q1); Medicine (miscellaneous) (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
184;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412703, 19412711;0.792;Q1;73;36;154;1481;347;134;2.02;41.14;United States;Northern America;Mary Ann Liebert Inc.;2008-2021;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2)"
185;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.79;Q2;52;81;222;1486;207;200;0.82;18.35;United States;Northern America;Taylor and Francis Ltd.;1991-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q2)"
186;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.786;Q2;42;32;109;3255;286;104;2.4;101.72;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
187;21841;Food Additives and Contaminants;journal;0265203X, 14645122;0.782;Q2;102;1;483;0;1392;475;2.29;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1984-2008;"Chemistry (miscellaneous) (Q1); Food Science (Q1); Public Health, Environmental and Occupational Health (Q1); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
188;22432;International Immunopharmacology;journal;18781705, 15675769;0.782;Q2;119;239;648;8936;1575;635;2.38;37.39;Netherlands;Western Europe;Elsevier;2001-2021;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
189;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.773;Q2;90;104;280;3920;592;277;1.9;37.69;United States;Northern America;Springer New York;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q1); Environmental Science (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Computational Theory and Mathematics (Q2); Mathematics (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3); Neuroscience (miscellaneous) (Q3)"
190;25096;Food and Chemical Toxicology;journal;18736351, 02786915;0.771;Q2;183;611;767;23399;2122;759;2.57;38.3;United Kingdom;Western Europe;Elsevier Ltd.;1982-2021;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2)"
191;20634;Journal of Texture Studies;journal;00224901, 17454603;0.769;Q1;57;38;119;1230;171;115;1.31;32.37;United States;Northern America;Wiley-Blackwell;1969-2021;"Food Science (Q1); Pharmaceutical Science (Q1)"
192;130063;Pharmacological Reports;journal;17341140;0.769;Q2;87;112;379;5277;920;378;2.25;47.12;Netherlands;Western Europe;Elsevier BV;2005-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
193;4000150314;Chemical Biology and Drug Design;journal;17470277;0.766;-;82;124;340;4416;655;327;2.41;35.61;United Kingdom;Western Europe;Blackwell;2006-2021;"Biochemistry (Q3); Molecular Medicine (Q3)"
194;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.764;Q2;112;160;268;6897;676;250;2.46;43.11;United States;Northern America;Academic Press Inc.;1970, 1981-2021;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
195;19984;Assay and Drug Development Technologies;journal;1540658X, 15578127;0.759;Q2;58;121;216;1523;408;160;1.64;12.59;United States;Northern America;Mary Ann Liebert Inc.;2002-2021;"Drug Discovery (Q2); Molecular Medicine (Q3)"
196;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117, 1533869X;0.755;Q2;38;30;65;1143;139;64;1.98;38.1;United States;Northern America;Old City Publishing;1996, 2002-2020;"Drug Discovery (Q2); Pharmacology (Q2); Cancer Research (Q3)"
197;4700152848;PPAR Research;journal;16874757, 16874765;0.747;Q2;52;117;52;9910;126;47;2.42;84.7;United States;Northern America;Hindawi Publishing Corporation;2006-2021;"Drug Discovery (Q2); Pharmacology (medical) (Q2)"
198;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.745;Q1;122;440;1455;13465;3105;1452;2.04;30.6;Japan;Asiatic Region;Pharmaceutical Society of Japan;1993-2021;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
199;23942;Biomedical Chromatography;journal;10990801, 02693879;0.743;Q2;68;187;462;4448;847;458;1.8;23.79;United Kingdom;Western Europe;John Wiley and Sons Ltd;1986-2021;"Medicine (miscellaneous) (Q1); Analytical Chemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
200;25214;Toxicologic Pathology;journal;15331601, 01926233;0.739;Q2;112;118;318;4338;736;307;1.99;36.76;United States;Northern America;SAGE Publications Inc.;1972-2021;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
201;21865;Fundamental and Clinical Pharmacology;journal;07673981, 14728206;0.732;Q2;77;76;229;3644;581;223;2.36;47.95;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1987-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
202;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.73;Q2;40;35;102;4756;209;102;2.09;135.89;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q1); Cardiology and Cardiovascular Medicine (Q2); Hematology (Q2); Pharmacology (Q2)"
203;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.714;Q2;109;108;376;3869;931;364;2.61;35.82;France;Western Europe;Elsevier Masson s.r.l.;1982-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
204;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;0.71;Q2;70;35;102;1412;211;98;2.19;40.34;United States;Northern America;Mary Ann Liebert Inc.;2011-2021;"Drug Discovery (Q2); Biochemistry (Q3); Genetics (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
205;15840;Journal of Antibiotics;journal;00218820, 18811469;0.709;Q2;84;97;310;1780;440;310;1.31;18.35;United Kingdom;Western Europe;Japan Antibiotics Research Association;1953-2021;"Drug Discovery (Q2); Pharmacology (Q2)"
206;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.707;Q2;96;120;401;3660;1027;371;2.53;30.5;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1979-2021;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
207;20027;BMC Pharmacology;journal;14712210;0.705;Q2;44;21;49;764;108;49;1.94;36.38;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
208;4200151509;Molecular Diagnosis and Therapy;journal;11771062;0.704;Q2;47;38;85;2967;205;81;2.41;78.08;United Kingdom;Western Europe;Adis International Ltd;2001, 2004, 2006-2021;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
209;22318;Toxicological Reviews;journal;11762551;0.686;Q2;46;0;49;0;160;42;3.3;0;United Kingdom;Western Europe;Adis International Ltd;2003-2006;"Pharmacology (Q2); Toxicology (Q2)"
210;25898;Journal of Peptide Science;journal;10752617, 10991387;0.685;Q2;68;157;316;6250;558;306;1.57;39.81;United Kingdom;Western Europe;John Wiley and Sons Ltd;1995-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3); Structural Biology (Q3)"
211;29053;Molecular Diversity;journal;1573501X, 13811991;0.683;Q2;58;23;118;866;311;113;3.04;37.65;Netherlands;Western Europe;Springer Netherlands;1995-1998, 2000, 2003-2021;"Drug Discovery (Q2); Information Systems (Q2); Inorganic Chemistry (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Molecular Biology (Q3); Catalysis (Q4)"
212;21744;Planta Medica;journal;14390221, 00320943;0.683;Q1;122;246;738;7128;1520;729;1.91;28.98;Germany;Western Europe;Georg Thieme Verlag;1961, 1965-2021;"Complementary and Alternative Medicine (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
213;21687;American Journal of PharmacoGenomics;journal;11752203;0.682;Q2;38;0;37;0;95;36;0;0;United Kingdom;Western Europe;Adis International Ltd;2001-2005;"Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
214;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.678;Q2;52;39;104;2051;184;97;1.76;52.59;United States;Northern America;Wiley-Liss Inc.;2003-2016;"Embryology (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Developmental Biology (Q3)"
215;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.674;Q2;64;55;104;2273;248;104;2.25;41.33;Netherlands;Western Europe;Springer Netherlands;1984-2021;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
216;16803;Antiviral Chemistry and Chemotherapy;journal;20402066, 09563202;0.671;Q2;54;17;98;901;199;97;1.92;53;United Kingdom;Western Europe;SAGE Publications Inc.;1991-2015, 2017-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Virology (Q3)"
217;24578;Mathematical Medicine and Biology;journal;14778599;0.669;Q2;46;23;58;703;120;57;1.69;30.57;United Kingdom;Western Europe;Oxford University Press;1984-2021;"Environmental Science (miscellaneous) (Q1); Applied Mathematics (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Immunology and Microbiology (miscellaneous)  (Q2); Medicine (miscellaneous) (Q2); Modeling and Simulation (Q2); Pharmacology (Q2); Neuroscience (miscellaneous) (Q3)"
218;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.664;Q2;95;357;1078;8580;1886;1078;1.73;24.03;Japan;Asiatic Region;Pharmaceutical Society of Japan;1958-2021;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2)"
219;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;0.663;Q2;98;188;692;6641;1305;686;1.77;35.32;United Kingdom;Western Europe;Nature Publishing Group;1980-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
220;14487;Journal of Ocular Pharmacology and Therapeutics;journal;15577732, 10807683;0.651;Q2;64;79;197;2632;338;195;1.6;33.32;United States;Northern America;Mary Ann Liebert Inc.;1987, 1991-1993, 1995-2021;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
221;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427843, 17427835;0.65;Q2;93;167;445;6510;963;437;2.14;38.98;United States;Northern America;Wiley-Blackwell;2004-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
222;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.649;Q2;81;242;533;8490;1074;529;1.94;35.08;Poland;Eastern Europe;Polish Physiological Society;1991-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
223;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.647;Q2;78;44;128;1508;288;119;2.33;34.27;Switzerland;Western Europe;S. Karger AG;1988-1997, 2004-2021;"Dermatology (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
224;19374;AAPS PharmSciTech;journal;15309932;0.643;Q1;101;167;301;4497;613;292;1.55;26.93;Switzerland;Western Europe;Springer International Publishing AG;2000-2021;"Pharmaceutical Science (Q1); Agronomy and Crop Science (Q2); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2)"
225;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484, 19404034;0.641;Q2;52;29;112;1475;207;104;1.83;50.86;United Kingdom;Western Europe;SAGE Publications Ltd;1996-2021;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
226;16573;Phytotherapy Research;journal;10991573, 0951418X;0.641;Q2;140;284;642;8600;1407;638;2.03;30.28;United Kingdom;Western Europe;John Wiley and Sons Ltd;1987-2021;Pharmacology (Q2)
227;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.636;Q2;81;61;206;1824;360;205;1.39;29.9;United Kingdom;Western Europe;Informa Healthcare;1984-2021;"Bioengineering (Q2); Colloid and Surface Chemistry (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2); Physical and Theoretical Chemistry (Q2)"
228;4700152603;Medicinal Chemistry;journal;15734064, 18756638;0.632;Q2;46;75;206;2780;447;206;2.05;37.07;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;Drug Discovery (Q2)
229;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.631;Q2;62;84;260;2737;414;251;1.48;32.58;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1978-2021;"Pharmacology (Q2); Veterinary (miscellaneous) (Q2)"
230;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.628;Q2;50;47;121;1442;275;118;2.24;30.68;United Kingdom;Western Europe;Taylor and Francis Ltd.;1993-2021;"Bioengineering (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
231;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;0.627;Q2;46;23;49;2218;112;49;2.29;96.43;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Oncology (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3)"
232;21256;Drugs of Today;journal;00257656, 16993993, 16994019;0.618;Q2;53;102;240;5033;513;238;2.01;49.34;Spain;Western Europe;Prous Science;1968, 1978-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
233;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.608;Q2;81;41;168;1841;415;168;1.91;44.9;Canada;Northern America;Canadian Society for Pharmaceutical Sciences;1998-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q2)"
234;23412;Journal of AOAC International;journal;10603271;0.606;Q2;90;192;668;5131;1105;659;1.37;26.72;United States;Northern America;AOAC International;1993-2021;"Agronomy and Crop Science (Q2); Analytical Chemistry (Q2); Food Science (Q2); Pharmacology (Q2); Environmental Chemistry (Q3)"
235;20770;Drug Delivery;journal;10717544, 15210464;0.602;Q2;72;64;163;1826;321;163;1.66;28.53;United Kingdom;Western Europe;Informa Healthcare;1993, 1995-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
236;23102;Journal of Pharmacy and Pharmacology;journal;20427158, 00223573;0.602;Q2;124;202;622;8250;1271;615;1.99;40.84;United Kingdom;Western Europe;Oxford University Press;1949-2021;"Pharmaceutical Science (Q2); Pharmacology (Q2)"
237;21100370879;"Journal of managed care &amp; specialty pharmacy";journal;23761032, 23760540;0.6;Q2;66;111;332;2835;396;229;1.22;25.54;United States;Northern America;Academy of Managed Care Pharmacy (AMCP);2014-2021;"Pharmacy (Q1); Health Policy (Q2); Pharmaceutical Science (Q2)"
238;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.598;Q2;90;160;370;4906;552;367;1.24;30.66;United States;Northern America;Informa Healthcare;1974, 1976-2021;"Drug Discovery (Q2); Pharmacology (Q2); Organic Chemistry (Q3)"
239;21352;Expert Opinion on Pharmacotherapy;journal;17447666, 14656566;0.595;Q2;83;294;742;21461;1669;724;2.41;73;United Kingdom;Western Europe;Taylor and Francis Ltd.;1999-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
240;19443;American Journal of Health-System Pharmacy;journal;10792082, 15352900;0.594;Q2;99;429;1298;6933;1479;871;1.11;16.16;United States;Northern America;American Society of Health-Systems Pharmacy;1995-2021;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
241;20570;Chemotherapy;journal;00093157, 14219794;0.592;Q2;58;71;232;2000;421;227;1.67;28.17;Switzerland;Western Europe;S. Karger AG;1960-2021;"Drug Discovery (Q2); Infectious Diseases (Q2); Medicine (miscellaneous) (Q2); Oncology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
242;21229;Drug News and Perspectives;journal;02140934;0.592;Q2;51;67;241;3253;355;239;1.35;48.55;Spain;Western Europe;Prous Science;1990-2010;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
243;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.588;Q2;63;103;280;2945;524;257;1.5;28.59;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1960-1961, 1996-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
244;7700153108;International Journal of Nanomedicine;journal;11782013, 11769114;0.58;Q2;145;52;106;2391;212;101;2;45.98;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Bioengineering (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Biomaterials (Q3); Biophysics (Q3); Nanoscience and Nanotechnology (Q3); Organic Chemistry (Q3)"
245;16533;Phytochemical Analysis;journal;09580344, 10991565;0.579;Q2;76;74;205;1671;376;205;1.67;22.58;United Kingdom;Western Europe;John Wiley and Sons Ltd;1990-2021;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Food Science (Q2); Medicine (miscellaneous) (Q2); Plant Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Molecular Medicine (Q3)"
246;4000148406;Clinical Toxicology;journal;15569519, 15563650;0.575;Q2;98;207;321;3955;543;270;1.71;19.11;United Kingdom;Western Europe;Informa Healthcare;1968-1998, 2005-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q2)"
247;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.574;Q2;91;119;216;5223;450;212;2.22;43.89;United Kingdom;Western Europe;John Wiley and Sons Ltd;1981-2021;Toxicology (Q2)
248;20026;BMC Clinical Pharmacology;journal;14726904;0.571;Q2;39;12;28;350;87;28;2.27;29.17;United Kingdom;Western Europe;BioMed Central Ltd.;2001-2012;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
249;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.571;Q2;62;51;149;2008;265;145;1.88;39.37;United States;Northern America;"John Wiley &amp; Sons Inc.";1998-2021;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2); Biochemistry (Q3); Molecular Medicine (Q3); Molecular Biology (Q4)"
250;22410;Inflammation Research;journal;1420908X, 10233830;0.57;Q2;94;123;361;3516;586;359;1.49;28.59;Switzerland;Western Europe;Birkhauser Verlag Basel;1995-2021;"Pharmacology (Q2); Immunology (Q3)"
251;25864;Heterocycles;journal;03855414;0.563;Q2;66;296;1157;9866;1342;1149;1.1;33.33;Japan;Asiatic Region;Japan Institute of Heterocyclic Chemistry;1983-2021;"Pharmacology (Q2); Analytical Chemistry (Q3); Organic Chemistry (Q3)"
252;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073, 18755402;0.561;Q2;66;84;260;5360;558;237;1.85;63.81;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;1998-2021;"Computer Science Applications (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q3)"
253;16319;IEEE Transactions on Nanobioscience;journal;15361241, 15582639;0.558;Q2;65;33;122;1037;257;115;1.52;31.42;United States;Northern America;Institute of Electrical and Electronics Engineers Inc.;2002-2021;"Biomedical Engineering (Q2); Biotechnology (Q2); Computer Science Applications (Q2); Electrical and Electronic Engineering (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Nanoscience and Nanotechnology (Q3)"
254;18077;Fitoterapia;journal;0367326X, 18736971;0.556;Q2;110;128;431;2107;714;431;1.41;16.46;Netherlands;Western Europe;Elsevier;1948-1949, 1961, 1972-2021;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
255;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.552;Q2;65;84;229;2673;382;226;1.35;31.82;Germany;Western Europe;Wiley-VCH Verlag;1822-1831, 1835-1933, 1937-1938, 1940, 1943-1944, 1950-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
256;20580;Journal of Food Biochemistry;journal;17454514, 01458884;0.542;Q2;50;53;143;1822;155;142;0.85;34.38;United States;Northern America;Wiley-Blackwell;1977-2021;"Food Science (Q2); Pharmacology (Q2); Biophysics (Q3); Cell Biology (Q3)"
257;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.542;Q1;23;12;41;351;71;41;2;29.25;United Kingdom;Western Europe;BioMed Central Ltd.;2002-2017;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2)"
258;14822;Xenobiotica;journal;00498254, 13665928;0.535;Q3;82;92;237;5011;513;235;2.14;54.47;United Kingdom;Western Europe;Informa Healthcare;1971-2021;"Medicine (miscellaneous) (Q2); Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
259;4700152769;Pharmacopeial Forum (discontinued);journal;03634655;0.531;Q3;19;16;31;169;22;31;0.89;10.56;United States;Northern America;United States Pharmacopeial Convention Inc.;1996-1998, 2000-2018;"Pharmacy (Q1); Drug Guides (Q2); Pharmacology (Q3)"
260;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.528;Q2;62;58;176;1434;229;173;1.17;24.72;United States;Northern America;Informa Healthcare;1996-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
261;16067;Reading Teacher;journal;00340561;0.526;Q3;53;81;230;1727;124;227;0.48;21.32;United States;Northern America;Wiley-Blackwell;1995-2021;"Linguistics and Language (Q1); Pharmacology (medical) (Q2); Pharmacology (Q3)"
262;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.524;Q3;88;121;375;4335;530;373;1.22;35.83;Netherlands;Western Europe;Elsevier;1996-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
263;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.519;Q3;76;96;255;2389;479;234;2.02;24.89;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1976-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
264;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.515;Q3;38;48;129;1420;141;126;1.07;29.58;Netherlands;Western Europe;Springer Netherlands;1996-2002, 2005-2021;"Analytical Chemistry (Q3); Biochemistry (Q3); Bioengineering (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
265;13248;Experimental and Toxicologic Pathology;journal;09402993, 16181433;0.508;Q3;70;83;187;2587;348;183;1.5;31.17;Germany;Western Europe;Urban und Fischer Verlag Jena;1992-2017;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q3); Cell Biology (Q4)"
266;21353;Expert Opinion on Therapeutic Patents;journal;13543776, 17447674;0.505;Q3;77;102;350;8712;430;339;1.18;85.41;United Kingdom;Western Europe;Taylor and Francis Ltd.;1991-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
267;25106;Human and Experimental Toxicology;journal;09603271;0.504;Q3;82;125;301;3827;516;282;1.55;30.62;United States;Northern America;SAGE Publications Inc.;1981-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
268;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785, 15578852;0.503;Q3;63;80;247;2813;389;237;1.35;35.16;United States;Northern America;Mary Ann Liebert Inc.;1996-2021;"Medicine (miscellaneous) (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3); Oncology (Q3); Pharmacology (Q3)"
269;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;0.492;Q3;34;23;47;2346;75;47;1.6;102;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2016;"Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2); Drug Discovery (Q3)"
270;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.487;Q2;61;57;158;1553;265;158;1.89;27.25;United Kingdom;Western Europe;John Wiley and Sons Ltd;1979-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
271;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X, 1414431X;0.487;Q1;91;174;621;5272;993;618;1.42;30.3;Brazil;Latin America;Associacao Brasileira de Divulgacao Cientifica;1973-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Biophysics (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3); Cell Biology (Q4)"
272;13671;Biologicals;journal;10958320, 10451056;0.481;Q3;60;55;150;1495;173;134;1.16;27.18;United States;Northern America;Academic Press Inc.;1990-2021;"Medicine (miscellaneous) (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biotechnology (Q3); Immunology and Microbiology (miscellaneous)  (Q3); Pharmacology (Q3)"
273;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.48;Q2;51;223;654;5747;786;649;1.1;25.77;United States;Northern America;Taylor and Francis Ltd.;1996-2021;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q3); Clinical Biochemistry (Q3)"
274;21194;Pharmacology;journal;00317012, 14230313;0.479;Q3;60;85;233;3110;384;233;1.9;36.59;Switzerland;Western Europe;S. Karger AG;1959-2021;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
275;22456;International Journal of Pharmacy Practice;journal;09617671, 20427174;0.472;Q2;39;111;128;1714;79;118;0.61;15.44;United Kingdom;Western Europe;Oxford University Press;1991-2021;"Pharmacy (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Public Health, Environmental and Occupational Health (Q2)"
276;14990;Current Neuropharmacology;journal;18756190, 1570159X;0.467;Q3;82;26;78;5205;83;75;1.18;200.19;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Psychiatry and Mental Health (Q2); Neurology (Q3); Neurology (clinical) (Q3); Pharmacology (Q3)"
277;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.459;Q3;69;82;283;1940;449;262;1.41;23.66;Germany;Western Europe;Dustri-Verlag Dr. Karl Feistle;1994-2021;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
278;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.458;Q3;79;136;276;4061;414;273;1.46;29.86;United Kingdom;Western Europe;Informa Healthcare;1985-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
279;21264;Drugs in R and D;journal;11796901, 11745886;0.455;Q3;47;43;127;2273;226;127;1.99;52.86;United Kingdom;Western Europe;Adis International Ltd;1999, 2002-2008, 2010-2021;Pharmacology (Q3)
280;110172;Progress in Drug Research;book series;0071786X;0.453;Q1;44;20;36;2384;58;33;2.85;119.2;Switzerland;Western Europe;Birkhauser Verlag Basel;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-2018;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
281;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.449;Q3;61;92;220;2537;369;189;1.44;27.58;United Kingdom;Western Europe;FRAME;1982, 1985-1986, 1988-1989, 1994-2021;"Medical Laboratory Technology (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q3)"
282;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.441;Q3;47;30;104;1477;194;102;2;49.23;United States;Northern America;Begell House Inc.;1984-1990, 1992-2021;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
283;26370;Molecules;journal;14203049;0.441;Q2;171;241;491;9228;638;475;1.29;38.29;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);1992, 1996-2021;"Chemistry (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Molecular Medicine (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
284;130047;Current Drug Discovery Technologies;journal;15701638;0.438;Q3;44;39;71;2701;140;69;1.84;69.26;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2004-2021;Drug Discovery (Q3)
285;144790;Marine Drugs;journal;16603397;0.438;Q3;128;34;47;2459;62;46;1.31;72.32;Switzerland;Western Europe;Multidisciplinary Digital Publishing Institute (MDPI);2003-2021;Drug Discovery (Q3)
286;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.436;Q3;36;24;65;745;72;65;0.87;31.04;Germany;Western Europe;Walter de Gruyter GmbH;1985-1988, 1990-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Pharmacology (Q3); Physiology (Q3)"
287;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.432;Q3;74;72;201;2448;314;200;1.67;34;United States;Northern America;Wiley-Blackwell;1986-2021;"Medicine (miscellaneous) (Q2); Process Chemistry and Technology (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biomedical Engineering (Q3); Biotechnology (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
288;21207;Drug Discovery Today: Technologies;journal;17406749;0.429;Q3;53;23;135;863;174;123;0.9;37.52;United Kingdom;Western Europe;Elsevier Ltd.;2004-2021;"Biotechnology (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
289;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.426;Q2;57;54;126;851;152;126;1.04;15.76;United States;Northern America;Informa Healthcare;2013-2021;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Biotechnology (Q3)"
290;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.425;Q3;62;64;209;3210;302;201;1.57;50.16;United States;Northern America;SAGE Publications Inc.;1982-2021;Toxicology (Q3)
291;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.421;Q3;76;234;852;4332;624;849;0.66;18.51;United States;Northern America;Springer New York;1966-2021;"Medicine (miscellaneous) (Q2); Pollution (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
292;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.421;Q3;67;129;342;2289;288;309;0.81;17.74;United States;Northern America;American Pharmacists Association;2003-2021;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q3)"
293;23489;Chemical Speciation and Bioavailability;journal;09542299;0.42;Q3;0;0;0;0;0;0;0;0;United Kingdom;Western Europe;Taylor and Francis Ltd.;1989-2018;"Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
294;4700152426;Current Pharmaceutical Analysis;journal;15734129;0.42;Q2;25;27;60;2132;67;60;1.12;78.96;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmaceutical Science (Q2); Biochemistry (Q3); Biophysics (Q3); Molecular Medicine (Q3)"
295;19958;Archives of Pharmacal Research;journal;19763786, 02536269;0.419;Q3;93;241;641;6424;863;641;1.2;26.66;South Korea;Asiatic Region;Pharmaceutical Society of Korea;1978-2021;"Drug Discovery (Q3); Organic Chemistry (Q3); Molecular Medicine (Q4)"
296;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.416;Q3;51;194;410;5402;474;402;1.28;27.85;India;Asiatic Region;Triveni Enterprises;1988-2021;"Environmental Engineering (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
297;27210;In Vivo;journal;17917549, 0258851X;0.415;Q3;64;135;474;4031;585;472;1.05;29.86;Greece;Western Europe;International Institute of Anticancer Research;1987-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
298;21192;Drug Development Research;journal;02724391, 10982299;0.413;Q3;62;59;237;3250;298;224;1.32;55.08;United States;Northern America;"John Wiley &amp; Sons Inc.";1981-2021;Drug Discovery (Q3)
299;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0.413;Q3;42;42;46;1681;93;46;2.02;40.02;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Public Health, Environmental and Occupational Health (Q2); Safety Research (Q2); Toxicology (Q3)"
300;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.412;Q3;46;37;103;1110;134;103;1.41;30;United States;Northern America;Informa Healthcare;1977-2021;"Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
301;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.412;Q3;58;130;355;3253;634;345;1.98;25.02;Italy;Western Europe;SAGE Publications Inc.;1989-2021;"Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3)"
302;21211;Pharmacy Education;journal;14772701, 15602214;0.409;Q2;18;9;118;142;43;117;0.3;15.78;Netherlands;Western Europe;;1973-1978, 2002-2021;"Pharmacy (Q1); Education (Q2); Pharmaceutical Science (Q2)"
303;22411;Inflammopharmacology;journal;09254692, 15685608;0.408;Q3;55;40;147;1893;189;142;1.19;47.33;Switzerland;Western Europe;Birkhauser Verlag Basel;1991-2021;"Pharmacology (medical) (Q2); Immunology (Q3); Pharmacology (Q3)"
304;21273;Journal of Immune Based Therapies and Vaccines;journal;14768518;0.406;Q3;21;8;25;340;31;25;1.06;42.5;United Kingdom;Western Europe;BioMed Central Ltd.;2003-2011;"Immunology (Q3); Pharmacology (Q3)"
305;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.392;Q3;53;76;146;2036;202;146;1.36;26.79;Japan;Asiatic Region;Japanese Society of Toxicological Sciences;1976-2021;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
306;19927;Methods and Findings in Experimental and Clinical Pharmacology;journal;03790355;0.391;Q3;53;77;215;2831;256;214;1.08;36.77;Spain;Western Europe;Prous Science;1979-2010;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
307;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.388;Q2;42;212;320;2304;270;320;0.73;10.87;United Kingdom;Western Europe;Taylor and Francis Ltd.;1998-2021;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
308;37697;Autonomic and Autacoid Pharmacology;journal;14748673, 14748665;0.382;Q3;21;13;112;439;100;111;0.89;33.77;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2002-2017;Pharmacology (Q3)
309;19441;American Journal of Drug Delivery;journal;11759038;0.375;Q3;22;0;49;0;59;43;1.54;0;United Kingdom;Western Europe;Adis International Ltd;2004-2006;Pharmacology (Q3)
310;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.373;Q2;63;105;232;2551;269;214;1.2;24.3;Netherlands;Western Europe;Springer Netherlands;2011-2021;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2); Pharmacy (Q2); Pharmacology (Q3); Toxicology (Q3)"
311;11700154733;Journal of Biomedical Nanotechnology;journal;15507041, 15507033;0.37;Q2;80;56;51;2993;54;48;1.06;53.45;United States;Northern America;American Scientific Publishers;2007-2020;"Materials Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Bioengineering (Q3); Biomedical Engineering (Q3); Nanoscience and Nanotechnology (Q4)"
312;6400153120;Chinese Medicine;journal;17498546;0.366;Q3;45;17;17;777;42;16;2.47;45.71;United Kingdom;Western Europe;BioMed Central Ltd.;2006-2021;"Complementary and Alternative Medicine (Q1); Pharmacology (Q3)"
313;21717;Die Pharmazie;journal;00317144;0.362;Q2;66;182;645;4259;691;642;1.01;23.4;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-2021;Pharmaceutical Science (Q2)
314;10900153328;Frontiers in Drug Design and Discovery;book series;15740889, 22121064;0.362;Q2;9;0;41;0;27;39;0.66;0;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2007, 2009, 2016-2018;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q4)"
315;4700152609;Current Computer-Aided Drug Design;journal;15734099;0.361;Q3;31;30;52;2612;63;48;1.21;87.07;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Molecular Medicine (Q4)"
316;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.36;Q1;69;148;372;2033;246;350;0.68;13.74;United States;Northern America;American Association of Colleges of Pharmacy;1945-1948, 1973-1989, 1991, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Education (Q2); Medicine (miscellaneous) (Q2)"
317;23009;Journal of Clinical Research;journal;13695207;0.359;Q3;11;3;7;113;13;7;0.33;37.67;United Kingdom;Western Europe;PJB Publications Ltd.;1998-2009;"Pharmacology (medical) (Q2); Pharmacology (Q3)"
318;25144;Journal of Health Science;journal;13475207, 13449702;0.357;Q3;49;104;355;3020;326;355;0.75;29.04;Japan;Asiatic Region;Pharmaceutical Society of Japan;1999-2011;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
319;15340;Developments in Biologicals;journal;14246074, 16622960;0.356;Q3;38;122;366;1574;326;361;0.76;12.9;Switzerland;Western Europe;S. Karger AG;2000-2008, 2010, 2012-2013;"Immunology (Q3); Pharmacology (Q3); Biomaterials (Q4)"
320;29845;IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer;book series;10171606;0.351;Q3;48;8;24;1070;33;23;1.38;133.75;France;Western Europe;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-2020;"Toxicology (Q3); Cancer Research (Q4)"
321;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.348;Q3;24;25;75;2377;72;70;0.85;95.08;United Arab Emirates;Middle East;Bentham Science Publishers;2012-2021;"Infectious Diseases (Q3); Pharmacology (Q3)"
322;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.348;Q3;53;68;154;2384;161;151;1;35.06;United Kingdom;Western Europe;Informa Healthcare;1978-2021;"Medicine (miscellaneous) (Q2); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3); Immunology (Q4)"
323;21208;Drug Discovery Today: Therapeutic Strategies;journal;17406773;0.346;Q3;29;37;183;1854;145;167;0.81;50.11;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
324;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X, 22124071;0.336;Q3;0;0;0;0;0;0;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2020;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Drug Discovery (Q3); Infectious Diseases (Q3)"
325;21262;Drugs under Experimental and Clinical Research;journal;03786501;0.335;Q3;39;0;36;0;62;36;0;0;Switzerland;Western Europe;Bioscience Ediprint Inc.;1980-2005;"Pharmacology (medical) (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
326;29947;Journal of Chemotherapy;journal;1120009X, 19739478;0.334;Q3;52;138;425;3892;392;385;0.72;28.2;United Kingdom;Western Europe;Maney Publishing;1989-2021;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3)"
327;19398;Acta Pharmaceutica;journal;18469558, 13300075;0.332;Q2;60;40;121;739;177;119;1.23;18.48;Croatia;Eastern Europe;Croatian Pharmaceutical Society;1986, 1992-2022;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
328;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0.332;Q2;54;36;97;1257;77;89;0.69;34.92;United States;Northern America;Elsevier Inc.;2005-2021;"Pharmaceutical Science (Q2); Pharmacy (Q2)"
329;5400152628;Revista Brasileira de Farmacognosia;journal;0102695X, 1981528X;0.328;Q2;50;123;93;4642;242;89;2.6;37.74;Brazil;Latin America;Springer Nature Switzerland AG;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
330;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;0.319;Q3;68;106;197;9775;199;194;1.01;92.22;United Kingdom;Western Europe;Informa Healthcare;2006-2021;Drug Discovery (Q3)
331;22204;Journal of Drug Delivery Science and Technology;journal;17732247, 25888943;0.313;Q2;52;63;205;2154;140;204;0.53;34.19;France;Western Europe;Editions de Sante;2004-2021;Pharmaceutical Science (Q2)
332;19700185200;Journal of Natural Medicines;journal;13403443, 18610293;0.31;Q2;50;94;191;2097;151;190;0.94;22.31;Germany;Western Europe;Springer Verlag;2006-2021;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Organic Chemistry (Q3)"
333;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;21070180, 03787966;0.305;Q3;39;34;101;751;87;95;0.79;22.09;France;Western Europe;Springer Paris;1976-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
334;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.304;Q2;61;190;608;3439;322;605;0.56;18.1;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-2021;Pharmaceutical Science (Q2)
335;130038;Letters in Drug Design and Discovery;journal;15701808;0.302;Q2;35;86;312;2044;220;312;0.71;23.77;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2005-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Molecular Medicine (Q4)"
336;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.3;Q3;64;28;123;868;73;102;0.49;31;United States;Northern America;Heldref Publications;2005-2021;"Environmental Science (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
337;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699, 09750983;0.296;Q2;48;158;740;3996;460;739;0.54;25.29;India;Asiatic Region;Scientific Publishers of India;1970, 1973-1978, 1981, 1989-1991, 1996-2018, 2020-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3)"
338;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.293;Q2;72;122;389;4032;277;389;0.65;33.05;United Kingdom;Western Europe;Taylor and Francis Ltd.;1961-1972, 1975-2021;"Complementary and Alternative Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
339;5800173383;Current Clinical Pharmacology;journal;15748847, 22123938;0.289;Q2;0;0;0;0;0;0;0;0;United Arab Emirates;Middle East;Bentham Science Publishers;2006-2020;"Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
340;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.283;Q2;66;49;119;1571;113;118;0.9;32.06;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;1979-2021;"Pharmaceutical Science (Q2); Aging (Q3); Chemistry (miscellaneous) (Q3); Colloid and Surface Chemistry (Q3); Dermatology (Q3); Drug Discovery (Q3)"
341;20545;PDA Journal of Pharmaceutical Science and Technology;journal;19482124, 10797440;0.283;Q2;40;44;131;1445;96;119;0.68;32.84;United States;Northern America;Parenteral Drug Association Inc.;1994-2021;Pharmaceutical Science (Q2)
342;4700152903;Forensic Toxicology;journal;18608965, 18608973;0.282;Q3;39;18;51;284;18;48;0.38;15.78;Japan;Asiatic Region;Springer Japan;2006-2021;"Biochemistry (medical) (Q3); Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
343;21265;Drugs of the Future;journal;03778282;0.281;Q3;45;119;850;6826;207;337;0.6;57.36;Spain;Western Europe;Prous Science;1978-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
344;19383;Fluoride - Quarterly Reports;journal;22534083, 00154725;0.28;Q3;48;58;128;953;132;123;1.06;16.43;New Zealand;Pacific Region;International Society for Fluoride Research;1973-2021;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3); Biochemistry (Q4)"
345;17700155034;Natural Product Communications;journal;15559475, 1934578X;0.28;Q3;50;342;339;9977;241;328;0.71;29.17;United States;Northern America;SAGE Publications Inc.;2006-2022;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Plant Science (Q3)"
346;22881;Yaoxue Xuebao;journal;05134870;0.279;Q2;34;217;705;4014;387;705;0.51;18.5;China;Asiatic Region;Chinese Pharmaceutical Association;1960, 1962-1966, 1979-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Molecular Medicine (Q4)"
347;21758;Prescrire International;journal;11677422;0.278;Q3;13;229;410;1762;145;347;0.36;7.69;France;Western Europe;Association Mieux Prescrire;1996-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
348;110097;Food and Drug Law Journal;journal;1064590X;0.275;Q3;22;43;105;6119;45;104;0.43;142.3;United States;Northern America;Food and Drug Law Institute;1992-2018, 2021;"Law (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3)"
349;22375;Indian Drugs;journal;0019462X;0.273;Q2;31;148;454;2607;111;454;0.23;17.61;India;Asiatic Region;Indian Drug Manufacturers' Association;1989-2021;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3)"
350;19978;Ars Pharmaceutica (discontinued);journal;00042927;0.27;Q2;20;36;80;775;42;80;0.51;21.53;Spain;Western Europe;Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017, 2021;"History and Philosophy of Science (Q2); Pharmaceutical Science (Q2)"
351;21100470510;Drug Research;journal;21949379, 21949387;0.27;Q3;65;128;384;2457;303;379;0.73;19.2;Germany;Western Europe;Thieme;1972, 2013-2021;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
352;145689;Alimentary Pharmacology and Therapeutics Symposium Series;journal;17466334;0.267;Q2;9;0;64;0;37;64;0.63;0;United Kingdom;Western Europe;;2005-2007;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
353;4700152607;Current Enzyme Inhibition;journal;15734080;0.267;Q3;18;20;54;1890;42;54;0.78;94.5;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Drug Discovery (Q3); Biochemistry (Q4); Molecular Medicine (Q4)"
354;22435;International Journal of Clinical Pharmacology Research;journal;02511649;0.266;Q2;31;0;25;0;40;25;0;0;Switzerland;Western Europe;Bioscience Ediprint Inc.;1981-2005;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
355;21102;Pharmaceutical Journal;journal;00316873;0.265;Q2;28;1114;4643;1056;150;652;0.04;0.95;United Kingdom;Western Europe;Pharmaceutical Press;1945-1949, 1994-2012, 2014-2017;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
356;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.264;Q3;62;79;300;1588;204;235;0.55;20.1;India;Asiatic Region;Wolters Kluwer Medknow Publications;1978-1980, 1982, 1984-1986, 1994-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
357;26767;Altex;journal;1868596X, 18688551;0.263;Q3;57;36;122;813;113;117;0.88;22.58;Germany;Western Europe;Springer International Publishing AG;2000-2021;"Medical Laboratory Technology (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
358;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.261;Q3;62;53;133;2690;109;131;0.75;50.75;United Kingdom;Western Europe;SAGE Publications Ltd;1985-2021;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
359;5800173394;Current Drug Therapy;journal;15748855;0.259;Q2;17;20;30;2194;20;28;0.67;109.7;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
360;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.255;Q3;48;81;458;1617;297;455;0.6;19.96;United Kingdom;Western Europe;John Wiley and Sons Ltd;1976-2021;"Drug Discovery (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Analytical Chemistry (Q4); Biochemistry (Q4); Organic Chemistry (Q4); Spectroscopy (Q4)"
361;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X, 15232859;0.255;Q3;20;84;189;487;84;187;0.46;5.8;United States;Northern America;Medical Letter Inc.;1965-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
362;20065;BioPharm International;trade journal;1542166X, 19391862;0.254;Q2;29;117;429;670;118;364;0.31;5.73;United States;Northern America;Advanstar Communications Inc.;2002-2020;"Pharmaceutical Science (Q2); Biotechnology (Q3)"
363;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.253;Q3;41;36;74;5869;41;25;0.58;163.03;Netherlands;Western Europe;Elsevier;1995-1997, 2000-2003, 2005-2006, 2008, 2012-2021;"Drug Discovery (Q3); Organic Chemistry (Q4)"
364;4500151530;Personalized Medicine;journal;17410541;0.252;Q3;33;79;94;2405;63;81;0.67;30.44;United Kingdom;Western Europe;Future Medicine Ltd.;2006-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
365;21496;Revista de Chimie (discontinued);journal;00347752;0.251;-;31;288;853;4918;277;853;0.35;17.08;Romania;Eastern Europe;Syscom 18 SRL;1973, 1996-2021;Chemistry (miscellaneous) (Q3)
366;4700151615;Scandinavian Journal of Work, Environment and Health, Supplement;journal;03566528;0.251;Q3;23;54;50;1887;37;43;1.03;34.94;Finland;Western Europe;Finnish Institute of Occupational Health;2005-2011, 2016-2018;"Geography, Planning and Development (Q2); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
367;59665;Chinese Journal of Natural Medicines;journal;16723651;0.248;Q3;40;102;292;1705;135;290;0.45;16.72;China;Asiatic Region;China Pharmaceutical University;2004-2021;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
368;20578;Journal of Food and Drug Analysis;journal;10219498;0.248;Q3;63;76;182;2190;107;180;0.51;28.82;Taiwan;Asiatic Region;National Laboratories of Foods and Drugs;1994-2021;"Food Science (Q3); Pharmacology (Q3)"
369;11500153306;Recent Patents on Drug Delivery and Formulation;journal;22124039, 18722113;0.246;Q2;36;22;22;2485;18;22;0.82;112.95;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Pharmaceutical Science (Q2); Biomedical Engineering (Q3); Medicine (miscellaneous) (Q3)"
370;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0.242;Q2;61;140;345;3870;353;337;1.06;27.64;China;Asiatic Region;Zhejiang University Press;2005-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Veterinary (miscellaneous) (Q3)"
371;24097;Journal of the Indian Chemical Society;journal;00194522;0.24;Q4;33;233;786;5316;264;781;0.33;22.82;India;Asiatic Region;Elsevier BV;1973-1985, 1987-1991, 1996-2021;"Drug Discovery (Q4); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
372;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0.239;Q3;42;77;175;1866;113;174;0.7;24.23;Pakistan;Asiatic Region;Pakistan Journal of Pharmaceutical Sciences;1995, 2005-2021;Pharmaceutical Science (Q3)
373;5800228222;Journal of Pharmaceutical Innovation;journal;18725120, 19398042;0.237;Q3;31;30;26;627;22;21;0.85;20.9;United States;Northern America;Springer New York;2006-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
374;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;0.237;Q4;28;24;54;2294;47;54;0.87;95.58;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006-2015;"Cardiology and Cardiovascular Medicine (Q3); Pharmacology (medical) (Q3); Drug Discovery (Q4)"
375;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.237;Q3;46;48;45;1339;18;45;0.29;27.9;Switzerland;Western Europe;MDPI AG;1949, 1960-1961, 1973-2021;Pharmaceutical Science (Q3)
376;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0.235;Q3;32;26;59;2055;39;55;0.66;79.04;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
377;25171;Mycotoxin Research;journal;18671632, 01787888;0.234;Q3;40;24;142;570;85;131;0.87;23.75;Germany;Western Europe;Springer-Verlag GmbH and Co. KG;1985-2021;"Biotechnology (Q3); Toxicology (Q3); Microbiology (Q4)"
378;26653;Journal of Herbal Pharmacotherapy;journal;15229106, 15228940;0.233;Q3;29;1;88;0;61;83;0.48;0;United States;Northern America;The Haworth Herbal Press;2001-2008;"Pharmacology (Q3); Biochemistry (Q4)"
379;20599;Paediatric and Perinatal Drug Therapy;journal;14630095;0.233;Q3;19;9;64;192;45;54;0.74;21.33;United Kingdom;Western Europe;Librapharm;1997-2008;"Pediatrics, Perinatology and Child Health (Q3); Pharmacology (Q3)"
380;22854;Yakugaku Zasshi;journal;13475231, 00316903;0.233;Q3;43;219;493;5425;292;483;0.58;24.77;Japan;Asiatic Region;Pharmaceutical Society of Japan;1961-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
381;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115, 20082231;0.223;Q3;47;54;111;1303;56;111;0.52;24.13;United Kingdom;Western Europe;BioMed Central Ltd.;2000-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
382;145096;Neuropsychopharmacologia Hungarica;journal;14198711;0.223;Q2;17;28;83;909;31;71;0.31;32.46;Hungary;Eastern Europe;Hungarian Association of Psychopharmacology;2004-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Neurology (clinical) (Q3); Neuropsychology and Physiological Psychology (Q3); Neuroscience (miscellaneous) (Q4)"
383;16698;Revista Brasileira de Plantas Medicinais;journal;1983084X, 15160572;0.223;Q3;29;65;147;1722;37;147;0.15;26.49;Brazil;Latin America;Instituto de Biociencias;1999-2016;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
384;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.223;Q3;10;32;108;374;15;108;0.19;11.69;France;Western Europe;Editions de Sante;1991-2014, 2017-2018;Pharmaceutical Science (Q3)
385;144613;Journal of Generic Medicines (discontinued);journal;17411343;0.22;Q3;15;42;133;451;33;116;0.28;10.74;United Kingdom;Western Europe;SAGE Publications Inc.;2003-2015, 2017, 2021;Pharmaceutical Science (Q3)
386;21100791826;Journal of Traditional Medicines;journal;18813747, 18801447;0.22;Q4;12;28;88;631;24;87;0.22;22.54;Japan;Asiatic Region;Medical and Pharmaceutical Society for WAKAN-YAKU;2004-2013;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q4)"
387;130072;International Journal of Medicinal Mushrooms;journal;15219437;0.218;Q3;33;44;97;1365;51;97;0.5;31.02;United States;Northern America;Begell House Inc.;2005-2021;"Applied Microbiology and Biotechnology (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
388;22906;Journal of China Pharmaceutical University;journal;10005048;0.217;Q3;14;124;399;1425;113;399;0.27;11.49;China;Asiatic Region;China Pharmaceutical University;1989-1991, 2002-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
389;15842;Journal of Applied Research;journal;1537064X;0.215;Q3;22;24;136;822;57;127;0.26;34.25;United States;Northern America;The Journal of Applied Research;2001-2014;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
390;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.215;Q3;46;95;169;3410;106;168;0.63;35.89;United Kingdom;Western Europe;Informa Healthcare;1991-2021;"Toxicology (Q3); Health, Toxicology and Mutagenesis (Q4)"
391;20564;Ceska a Slovenska Farmacie;journal;12107816;0.213;Q3;17;42;141;1101;29;140;0.26;26.21;Czech Republic;Eastern Europe;Czech Medical Association J.E. Purkyne;1994-2021;Pharmaceutical Science (Q3)
392;22908;Chinese Pharmacological Bulletin;journal;10011978;0.212;Q3;17;417;1118;6074;676;1118;0.78;14.57;China;Asiatic Region;Institute of Clinical Pharmacology;1993-2020;Pharmacology (Q3)
393;79053;Natural Product Sciences;journal;12263907;0.212;Q4;28;52;173;1099;60;173;0.31;21.13;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1997-2021;"Drug Discovery (Q4); Organic Chemistry (Q4)"
394;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0.211;Q3;32;61;111;1691;38;102;0.34;27.72;United Kingdom;Western Europe;Centro de Estudos de Venenos e Animais Peconhentos;2006-2021;"Infectious Diseases (Q3); Toxicology (Q3); Animal Science and Zoology (Q4); Parasitology (Q4)"
395;145524;Drug Discovery Today: Disease Mechanisms;journal;17406765;0.208;Q4;27;38;197;2432;81;175;0.41;64;United Kingdom;Western Europe;Elsevier Ltd.;2004-2013;"Drug Discovery (Q4); Molecular Medicine (Q4)"
396;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0.208;Q3;28;32;65;836;28;65;0.43;26.13;Spain;Western Europe;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-2021;"Pharmacy (Q2); Pharmaceutical Science (Q3)"
397;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.205;Q3;53;60;207;1627;106;169;0.42;27.12;India;Asiatic Region;Association of Physiologists and Pharmacologists of India;1959-2021;"Pharmacology (Q3); Physiology (Q4); Physiology (medical) (Q4)"
398;12000154522;Advances in Antiviral Drug Design;book series;10758593;0.204;Q2;12;0;7;0;2;6;0.29;0;United Kingdom;Western Europe;Elsevier Ltd.;1996, 1999, 2003, 2007;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Infectious Diseases (Q3); Pharmacology (medical) (Q3); Virology (Q4)"
399;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0.204;Q3;33;21;78;917;59;75;0.79;43.67;Spain;Western Europe;Elsevier Espana;2005-2021;"Agricultural and Biological Sciences (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q4)"
400;35190;Revista Espanola de Quimioterapia;journal;02143429;0.204;Q3;26;41;152;1635;87;139;0.64;39.88;Spain;Western Europe;Sociedad Espanola de Quiminoterapia;1989-2021;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3)"
401;21795;Farmaceuticky Obzor (discontinued);journal;00148172;0.202;Q3;7;35;106;530;15;106;0.13;15.14;Slovakia;Eastern Europe;Postgraduate Medical and Pharmaceutical School;1961-1963, 1974, 1976-2016;Pharmaceutical Science (Q3)
402;21811;Farmacia Hospitalaria;journal;21718695, 11306343;0.202;Q3;24;76;238;1367;95;135;0.38;17.99;Spain;Western Europe;Grupo Aula Medica S.A.;1990-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
403;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.201;Q3;43;83;188;2903;104;179;0.4;34.98;Brazil;Latin America;Faculdade de Ciencias Farmaceuticas (Biblioteca-;2009-2020;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
404;5800173401;Current Bioactive Compounds;journal;15734072;0.201;Q3;27;25;17;1887;13;16;0.76;75.48;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
405;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0.201;Q3;11;153;199;1075;27;182;0.14;7.03;United States;Northern America;International Journal of Pharmaceutical Compounding;2006-2021;"Pharmacology (nursing) (Q2); Pharmacy (Q2); Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
406;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.201;Q3;19;46;156;730;21;135;0.18;15.87;United States;Northern America;SAGE Publications Inc.;2000-2015, 2017-2018;"Marketing (Q3); Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Strategy and Management (Q3)"
407;73430;Pharmaceutical Technology;journal;15432521;0.201;Q3;38;207;570;1147;109;393;0.19;5.54;United States;Northern America;Advanstar Communications Inc.;1979-1985, 1987, 1996-2021;"Pharmaceutical Science (Q3); Biophysics (Q4)"
408;20684;Current Pharmacogenomics;journal;15701603;0.2;Q3;12;0;84;0;40;84;0.37;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2004-2007;"Pharmacology (Q3); Genetics (Q4)"
409;144963;Drug Discovery Today: Disease Models;journal;17406757;0.197;Q4;28;38;147;2088;64;131;0.49;54.95;United Kingdom;Western Europe;Elsevier Ltd.;2004-2020;"Drug Discovery (Q4); Molecular Medicine (Q4)"
410;22357;IDrugs : the investigational drugs journal;journal;13697056, 20403410;0.196;Q3;35;167;558;1085;226;554;0.41;6.5;United Kingdom;Western Europe;Current Drugs Ltd.;1998-2010;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Drug Discovery (Q4)"
411;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.194;Q4;40;49;94;2741;53;93;0.52;55.94;United States;Northern America;Informa Healthcare;2004-2021;"Immunology (Q4); Toxicology (Q4)"
412;13718;Pharmaceutical Engineering;journal;02738139;0.194;Q3;16;45;172;274;25;151;0.16;6.09;United States;Northern America;Int. Society for Pharmaceutical Engineering, Inc.;1996-2018;Pharmaceutical Science (Q3)
413;5200152843;Farmaceutico Hospitales;journal;02144697;0.192;Q3;3;27;53;282;10;41;0.19;10.44;Spain;Western Europe;Ediciones Mayo S.A.;2006-2012;"Pharmaceutical Science (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
414;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.192;Q3;19;234;703;1207;45;678;0.06;5.16;Germany;Western Europe;Editio Cantor Verlag GmbH;1960-1961, 1973-2019;Pharmaceutical Science (Q3)
415;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.19;Q4;9;26;58;400;8;58;0.18;15.38;India;Asiatic Region;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-2021;"Pathology and Forensic Medicine (Q3); Toxicology (Q4)"
416;11100153314;Frontiers in Medicinal Chemistry;book series;18755763, 15742042;0.189;Q4;7;0;27;0;8;26;0.3;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2006, 2009-2010;"Drug Discovery (Q4); Molecular Medicine (Q4); Organic Chemistry (Q4)"
417;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.189;Q3;14;48;77;5042;24;68;0.31;105.04;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2018;"Endocrinology, Diabetes and Metabolism (Q3); Immunology and Allergy (Q3); Pharmacology (Q3)"
418;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.188;Q3;6;40;120;188;9;118;0.12;4.7;United States;Northern America;Russell Publishing LLC;2010-2018, 2021;"Health Policy (Q3); Pharmaceutical Science (Q3)"
419;21227;Pharmacy in Practice;journal;13581538;0.188;Q3;5;56;202;840;20;172;0.11;15;United Kingdom;Western Europe;Medicom Publishing;1995-2009;"Pharmacy (Q2); Health Policy (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
420;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.188;Q3;9;38;111;671;11;105;0.07;17.66;Cuba;Latin America;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3); Pharmacy (Q3)"
421;22934;Chinese Pharmaceutical Journal;journal;10012494;0.187;Q3;21;527;1434;5587;299;1434;0.2;10.6;China;Asiatic Region;Chinese Pharmaceutical Association;1993-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
422;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.185;Q3;36;19;35;1084;26;34;0.78;57.05;Germany;Western Europe;Walter de Gruyter GmbH;2015-2021;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
423;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.184;Q3;45;120;259;2495;106;259;0.47;20.79;Poland;Eastern Europe;Polish Pharmaceutical Society;1951-1955, 1961-2021;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
424;73076;Drug Discovery World;journal;14694344;0.184;Q4;13;27;114;245;34;103;0.33;9.07;United Kingdom;Western Europe;RJ Communications and Media Ltd.;2004-2018;Drug Discovery (Q4)
425;130007;Drug Design Reviews Online;journal;15672697;0.183;Q3;10;0;48;0;24;48;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2005;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
426;19446;American Pharmaceutical Review;journal;10998012;0.181;Q3;24;97;312;1551;98;305;0.29;15.99;United States;Northern America;Russell Publishing LLC;2002-2020;Pharmaceutical Science (Q3)
427;50105;Japanese Journal of Neuropsychopharmacology;journal;03887588, 13434144;0.181;Q3;11;28;96;1053;26;96;0.31;37.61;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1982-1997, 2002-2017;"Clinical Psychology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3)"
428;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.179;Q4;32;34;82;722;43;80;0.66;21.24;United Kingdom;Western Europe;Informa Healthcare;1982-2000, 2005-2021;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
429;144879;Toxicology International;journal;09716580;0.178;Q4;28;25;65;615;10;65;0.13;24.6;India;Asiatic Region;Society of Toxicology India;2005-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
430;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.175;Q3;32;668;1438;7867;413;1438;0.24;11.78;China;Asiatic Region;Zhongguo Zhongyi Yanjiuyuan;1989-2021;"Complementary and Alternative Medicine (Q2); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
431;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0.174;Q3;59;146;173;8343;100;162;0.58;57.14;New Zealand;Pacific Region;Dove Medical Press Ltd.;2006-2021;"Chemical Health and Safety (Q2); Safety Research (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
432;130089;Toxin Reviews;journal;15569543, 15569551;0.174;Q4;46;19;69;1383;32;65;0.56;72.79;United Kingdom;Western Europe;Informa Healthcare;1982-2021;Toxicology (Q4)
433;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.173;Q4;37;39;130;1181;66;130;0.35;30.28;Croatia;Eastern Europe;Institute for Medical Research and Occupational Health;1953-2021;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q4)"
434;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.172;Q3;10;21;95;210;17;92;0.35;10;Netherlands;Western Europe;IOS Press BV;1999, 2001-2002, 2005, 2007-2018;"Health Policy (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
435;130006;Medicinal Chemistry Reviews - Online;journal;15672034;0.171;Q4;7;0;46;0;19;46;0;0;Netherlands;Western Europe;Bentham Science Publishers B.V.;2005;"Drug Discovery (Q4); Molecular Medicine (Q4)"
436;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.17;Q3;24;38;145;3137;36;129;0.24;82.55;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Immunology (Q4); Immunology and Allergy (Q4)"
437;24071;Metal-Based Drugs;journal;07930291, 16875486;0.168;Q3;38;18;5;1003;8;4;1.6;55.72;United States;Northern America;Hindawi Publishing Corporation;1996-2002, 2007-2011;"Pharmacology (Q3); Drug Discovery (Q4); Inorganic Chemistry (Q4); Toxicology (Q4)"
438;21412;Zeitschrift fur Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.168;Q3;13;71;192;620;24;121;0.12;8.73;Germany;Western Europe;Hippokrates Verlag GmbH;1982, 1985-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3)"
439;22825;Proceedings of the Western Pharmacology Society;journal;00838969;0.166;Q3;24;22;130;406;39;130;0.09;18.45;United States;Northern America;Western Pharmacology Society;1960-1969, 1973-2011;Pharmacology (Q3)
440;19700180781;Strategies and Tactics in Organic Synthesis;book series;18746004;0.165;Q4;10;15;17;1147;5;14;0;76.47;United States;Northern America;Academic Press Inc.;2004-2005, 2008, 2012-2017, 2019;"Drug Discovery (Q4); Organic Chemistry (Q4)"
441;25253;Blutalkohol (discontinued);journal;00065250;0.164;Q4;13;32;89;321;9;83;0.1;10.03;Germany;Western Europe;Steintor-Verlag GmbH;1974-2017, 2020-2021;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
442;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0.164;Q3;25;16;43;677;10;40;0.23;42.31;Singapore;Asiatic Region;Elsevier;2005-2021;"Pharmacology (nursing) (Q2); Pharmaceutical Science (Q3); Sports Science (Q4)"
443;19381;Acta Farmaceutica Bonaerense;journal;03262383;0.163;Q3;0;0;0;0;0;0;0;0;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;1989-2006;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
444;22514;Japanese Journal of Chemotherapy;journal;13407007;0.163;Q3;12;44;177;682;62;177;0.2;15.5;Japan;Asiatic Region;Japan Society of Chemotherapy;1995-2021;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
445;4700152608;African Journal of Traditional, Complementary and Alternative Medicines (discontinued);journal;25050044, 01896016;0.16;Q4;48;23;126;716;42;122;0.33;31.13;Nigeria;Africa;African Ethnomedicines Network;2006-2017;"Complementary and Alternative Medicine (Q3); Medicine (miscellaneous) (Q3); Drug Discovery (Q4)"
446;18384;Medicinal Chemistry Research;journal;10542523, 15548120;0.16;Q3;50;59;249;1424;53;249;0.18;24.14;United States;Northern America;Birkhauser Boston;1994, 1996-2021;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Organic Chemistry (Q4)"
447;9800153137;Trastornos Adictivos;journal;15750973;0.16;Q3;9;28;32;980;13;22;0.41;35;Spain;Western Europe;Ediciones Doyma, S.L.;2007-2012;"Pharmacology (Q3); Psychiatry and Mental Health (Q3)"
448;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.156;Q3;27;50;161;1411;66;156;0.45;28.22;France;Western Europe;Elsevier Masson s.r.l.;1945, 1947-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
449;130031;Journal of Toxicologic Pathology;journal;09149198;0.156;Q4;30;39;78;2271;24;78;0.37;58.23;Japan;Asiatic Region;Japanese Society of Toxicologic Pathology;1988-1990, 1992-2021;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
450;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.156;Q4;14;16;54;31;14;54;0.22;1.94;Japan;Asiatic Region;Nihon Sangyo Eisei Gakkai;1995-2021;"Medicine (miscellaneous) (Q3); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
451;21127;Pharmaceutical Technology Europe;journal;01646826;0.155;Q3;18;121;327;785;52;208;0.13;6.49;United States;Northern America;Advanstar Communications Inc.;1998-2020;Pharmaceutical Science (Q3)
452;11200153563;Drug Metabolism Letters;journal;18740758, 18723128;0.154;Q3;28;48;53;1355;23;52;0.43;28.23;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2019, 2021;"Biochemistry (medical) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Clinical Biochemistry (Q4)"
453;23074;Journal of Pharmaceutical Finance, Economics and Policy;journal;15385396, 15385698;0.153;Q3;7;24;45;710;11;37;0.14;29.58;United States;Northern America;Haworth Press Inc.;2003-2008;"Health Policy (Q3); Pharmaceutical Science (Q3); Pharmacology (Q4)"
454;21142;Pharmaceutisch Weekblad;journal;00316911;0.153;Q4;9;368;1698;418;13;997;0.01;1.14;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);1948-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
455;4100151616;Supportive Cancer Therapy;journal;15432912;0.153;Q4;14;0;66;0;20;55;0.3;0;United States;Northern America;Cancer Information Group, LP;2006-2007;"Oncology (Q3); Cancer Research (Q4); Pharmacology (Q4)"
456;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.15;Q3;18;36;117;1078;22;117;0.2;29.94;Brazil;Latin America;Universidade Estadual Paulista - UNESP;2005-2021;Pharmaceutical Science (Q3)
457;12328;Current Therapeutic Research;journal;0011393X, 18790313;0.149;Q4;42;44;121;1279;49;116;0.28;29.07;United States;Northern America;Elsevier Inc.;1959-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
458;3900148201;International Journal of Pharmacology (discontinued);journal;18125700, 18117775;0.149;Q4;39;81;220;2496;57;220;0.26;30.81;Pakistan;Asiatic Region;Asian Network for Scientific Information;2006-2018, 2020-2021;Pharmacology (Q4)
459;19700180827;Progress in Pharmaceutical and Biomedical Analysis;book series;14643456;0.148;Q3;8;0;14;0;7;12;0;0;United Kingdom;Western Europe;Elsevier Ltd.;1994, 1996, 2000, 2003, 2005;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Biomedical Engineering (Q4); Biotechnology (Q4)"
460;19600162009;Advances in Molecular Toxicology;book series;18720854, 22122044;0.146;Q4;15;8;6;1048;1;5;0.17;131;Netherlands;Western Europe;Elsevier;2006, 2008-2018, 2020;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (Q4); Toxicology (Q4)"
461;5800173386;Current Drug Safety;journal;15748863;0.146;Q4;37;33;63;1626;26;62;0.41;49.27;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2006-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4); Toxicology (Q4)"
462;5100152606;Biosciences Biotechnology Research Asia (discontinued);journal;09731245;0.145;Q4;18;155;339;2645;30;338;0.1;17.06;India;Asiatic Region;Oriental Scientific Publishing Company;2005-2016;"Agronomy and Crop Science (Q4); Biotechnology (Q4); Drug Discovery (Q4)"
463;145693;Canadian Pharmacists Journal;journal;17151635;0.145;Q3;24;79;442;556;30;240;0.09;7.04;Canada;Northern America;Canadian Pharmacists Association;2005-2021;"Pharmaceutical Science (Q3); Pharmacy (Q3)"
464;4000151610;International Journal of Neuroprotection and Neuroregeneration;journal;17451183, 17451191;0.145;Q4;5;11;44;581;12;39;0.27;52.82;United Kingdom;Western Europe;RPA Publishers.;2006-2008;"Neurology (clinical) (Q4); Pharmacology (Q4)"
465;23171;Korean Journal of Pharmacognosy;journal;02533073;0.145;Q3;17;62;184;1364;36;184;0.18;22;South Korea;Asiatic Region;Korean Society of Pharmacognosy;1990-2011, 2013-2021;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
466;22977;Journal de Pharmacie de Belgique;journal;00472166;0.144;Q3;12;23;69;345;11;66;0.14;15;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
467;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.144;Q4;22;34;101;846;25;101;0.18;24.88;India;Asiatic Region;Informatics Publishing Limited;2002-2021;Pharmacology (Q4)
468;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;0.143;Q4;30;85;70;2874;10;68;0.14;33.81;United States;Northern America;Current Medicine Group;2007-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
469;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X, 22122710;0.142;Q4;29;27;28;2069;11;28;0.39;76.63;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2007-2020;"Medicine (miscellaneous) (Q3); Drug Discovery (Q4); Immunology and Allergy (Q4)"
470;22205;Saudi Pharmaceutical Journal;journal;13190164;0.142;Q3;57;31;78;1077;10;78;0.13;34.74;Saudi Arabia;Middle East;King Saud University;1996-2021;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
471;19700174893;Dhaka University Journal of Pharmaceutical Sciences (discontinued);journal;18161839, 18161820;0.141;Q3;13;32;26;488;4;26;0.15;15.25;Bangladesh;Asiatic Region;University of Dhaka;2007-2018, 2020;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
472;19700189100;Pharmaceutical Medicine;journal;11782595, 11791993;0.141;Q4;19;40;144;1355;40;129;0.37;33.88;United Kingdom;Western Europe;Adis International Ltd;2000-2001, 2008-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
473;10300153342;Journal of Medical Toxicology;journal;15569039, 19376995;0.14;Q4;52;56;86;179;31;74;0.37;3.2;United States;Northern America;Springer New York;2005-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
474;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.14;Q4;5;20;35;412;4;35;0.18;20.6;Japan;Asiatic Region;Japanese Society of Oral Therapeutics and Pharmacology;1982-2021;"Dentistry (miscellaneous) (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
475;21800;Farmacevtski Vestnik (discontinued);journal;00148229;0.139;Q4;4;51;87;1265;3;86;0.03;24.8;Slovenia;Eastern Europe;Slovenian Pharmaceutical Society;1961, 1989-2016;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
476;5000158117;Profiles of Drug Substances, Excipients and Related Methodology;journal;18715125;0.139;Q3;21;3;29;313;5;24;0;104.33;United States;Northern America;Academic Press Inc.;2001-2003, 2005, 2007-2021;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Molecular Medicine (Q4); Pharmacology (Q4)"
477;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.138;Q4;20;11;67;191;10;67;0.18;17.36;Turkey;Middle East;Istanbul Medipol University;2006-2011, 2016-2021;Pharmaceutical Science (Q4)
478;23173;Korean Journal of Physiology and Pharmacology;journal;20933827, 12264512;0.138;Q4;33;52;142;1634;16;142;0.13;31.42;South Korea;Asiatic Region;Korean Physiological Soc. and Korean Soc. of Pharmacology;1997-2021;"Pharmacology (Q4); Physiology (Q4)"
479;21716;Pharmazeutische Zeitung;journal;00317136;0.138;Q4;7;458;1355;952;11;570;0.01;2.08;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-2021;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
480;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185, 22312730;0.136;Q4;35;136;305;1769;10;211;0.03;13.01;India;Asiatic Region;Wolters Kluwer Medknow Publications;1996-1999, 2002-2021;"Anesthesiology and Pain Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
481;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.136;Q4;29;48;59;1358;16;59;0.3;28.29;United States;Northern America;Taylor and Francis Ltd.;1992-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
482;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.135;Q4;15;89;300;1737;44;300;0.16;19.52;Russian Federation;Eastern Europe;Izdatelstvo Meditsina;1992-2021;"Medicine (miscellaneous) (Q3); Pharmacology (Q4); Toxicology (Q4)"
483;5800179590;Pharmacologyonline (discontinued);journal;18278620;0.135;Q4;27;222;157;5122;37;157;0.24;23.07;Italy;Western Europe;SILAE - Societa Italo-Latinoamericana di Etnomedicina;2007-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
484;70864;Anales de la Real Academia Nacional de Farmacia (discontinued);journal;1697428X, 16974271;0.134;Q4;10;16;121;721;14;118;0.09;45.06;Spain;Western Europe;Real Academia Nacional de Farmacia;1988-2018;"Pharmacology (medical) (Q3); Cell Biology (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4)"
485;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.134;Q4;12;80;240;1497;42;240;0.2;18.71;China;Asiatic Region;Chinese Journal of Pharmacology and Toxicology;1986-2020;"Pharmacology (Q4); Toxicology (Q4)"
486;80593;Journal of Medicinal Plants;journal;16840240;0.134;Q4;23;62;142;1448;22;142;0.15;23.35;Iran;Middle East;;2004-2021;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
487;4900152705;NATO Security through Science Series A: Chemistry and Biology;book series;18714641;0.134;Q4;14;26;189;510;42;188;0.22;19.62;Germany;Western Europe;Springer Verlag;2006-2008;"Biotechnology (Q4); Chemistry (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
488;20572;PZ Prisma;journal;09455566;0.133;Q4;5;31;100;660;6;88;0.06;21.29;Germany;Western Europe;Govi-Verlag Pharmazeutischer Verlag GmbH;1994-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
489;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.132;Q4;17;16;31;522;7;31;0.19;32.63;United States;Northern America;Informa Healthcare;1983-1990, 1992-2016;"Pharmacology (medical) (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
490;21798;Farmaceutski Glasnik;journal;00148202;0.131;Q4;6;78;50;379;6;50;0.14;4.86;Croatia;Eastern Europe;Hrvatsko Farmaceutsko Drustvo;1950-1951, 1962, 1990-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
491;58808;Pharmaceutical Care and Research;journal;16712838;0.131;Q4;8;160;329;1309;20;329;0.05;8.18;China;Asiatic Region;Publishing House of Pharmaceutical Care and Research;2004-2021;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
492;17783;Research Communications in Molecular Pathology and Pharmacology;journal;10780297;0.131;Q4;39;0;32;0;7;32;0.39;0;United States;Northern America;PJD Publications Ltd;1994-2007, 2009;"Medicine (miscellaneous) (Q3); Molecular Medicine (Q4); Pharmacology (Q4)"
493;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.13;Q4;34;175;477;2726;84;477;0.17;15.58;United States;Northern America;Springer New York;1967-2021;"Drug Discovery (Q4); Pharmacology (Q4)"
494;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0.13;Q4;16;19;30;428;5;30;0.17;22.53;Turkey;Middle East;Turkish Pharmacists  Association;2006-2021;"Molecular Medicine (Q4); Pharmaceutical Science (Q4)"
495;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0.129;Q4;17;317;633;4230;76;633;0.12;13.34;China;Asiatic Region;Editorial Office of Chinese Traditional and Herbal Drugs;2006-2021;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
496;22338;Hospital Pharmacy;journal;19451253, 00185787;0.128;Q4;24;146;422;1878;51;379;0.14;12.86;United States;Northern America;Thomas Land Publishers Inc.;1973-2021;"Pharmacy (Q3); Pharmacology (Q4); Pharmacology (medical) (Q4)"
497;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.128;Q4;16;121;243;1886;24;243;0.11;15.59;Japan;Asiatic Region;Life Science Publishing Co. Ltd;1981-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
498;19700174971;Indian Journal of Forensic Medicine and Toxicology (discontinued);journal;09739122, 09739130;0.126;Q4;12;19;0;302;0;0;0;15.89;India;Asiatic Region;Institute of Medico-legal Publications;2008-2021;"Law (Q3); Health, Toxicology and Mutagenesis (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
499;21718;Pharmazie in Unserer Zeit;journal;00483664, 16151003;0.125;Q4;13;85;235;952;26;177;0.12;11.2;Germany;Western Europe;Wiley-VCH Verlag;1972-2012;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
500;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.125;Q4;14;23;55;333;3;49;0.04;14.48;Cuba;Latin America;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-2020;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
501;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;0.124;Q4;21;31;70;965;16;70;0.23;31.13;Iran;Middle East;Academy of Medical Sciences of I.R. Iran;2006-2015;Pharmacology (Q4)
502;19399;Acta Pharmaceutica Hungarica (discontinued);journal;00016659;0.123;Q4;14;19;77;446;5;77;0.04;23.47;Hungary;Eastern Europe;Magyar Gyogyszereszeti Tarsasag;1965-2018;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q4)"
503;16893;Biogenic Amines;journal;15693910, 01688561;0.123;Q4;15;0;75;0;19;74;0.14;0;Slovenia;Eastern Europe;Society of Integrated Sciences;1989-2007;"Neuroscience (miscellaneous) (Q4); Pharmacology (Q4)"
504;130170;Phytotherapie;journal;17652847, 16248597;0.121;Q4;18;68;176;1239;15;118;0.08;18.22;France;Western Europe;Springer Paris;2005-2020;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
505;4000151703;Core Evidence (discontinued);journal;15551741, 1555175X;0.12;Q4;25;18;30;1192;2;29;0;66.22;New Zealand;Pacific Region;Dove Medical Press Ltd.;2005-2018;"Reviews and References (medical) (Q1); Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
506;15240;Iranian Journal of Medical Sciences;journal;17353688, 02530716;0.12;-;31;50;178;1064;20;163;0.1;21.28;Iran;Middle East;Shiraz University of Medical Sciences;1979-1981, 1989-2021;Medicine (miscellaneous) (Q4)
507;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;0.12;Q4;6;14;15;444;4;13;0.27;31.71;Switzerland;Western Europe;Springer Science + Business Media;2007-2018;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
508;17716;Quality Assurance Journal;journal;10991786, 10878378;0.12;Q4;9;0;86;0;5;73;0.08;0;United Kingdom;Western Europe;John Wiley and Sons Ltd;1998, 2000-2007, 2009-2011;"Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
509;13000154717;Current Topics in Toxicology;journal;09728228;0.119;Q4;7;4;7;166;2;7;0.29;41.5;India;Asiatic Region;Research Trends;2007-2009, 2011-2021;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
510;3300147901;EMC - Toxicologie-Pathologie;journal;17625858;0.119;Q4;6;0;14;0;5;14;0;0;France;Western Europe;Editions scientifique et medicales Elsevier SAS;2004-2005;"Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
511;22979;Journal of Applied Therapeutic Research;journal;10292659;0.119;Q4;8;12;19;205;6;19;0.33;17.08;United Kingdom;Western Europe;Euromed Communications;1998-2000, 2003-2012;Pharmacology (Q4)
512;23107;Journal of Pharmacy Technology;journal;15494810, 87551225;0.119;Q4;13;26;113;731;12;102;0.1;28.12;United States;Northern America;SAGE Publications Inc.;1989-2021;Pharmaceutical Science (Q4)
513;25196;Revista Brasileira de Toxicologia;journal;14152983;0.119;Q4;7;13;32;421;4;32;0;32.38;Brazil;Latin America;Sociedade Brasileira de Toxicologia;2000-2010;Toxicology (Q4)
514;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.117;Q4;5;40;135;757;5;135;0.06;18.93;Bulgaria;Eastern Europe;PHARMAKON-Press;1989-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
515;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.115;Q4;11;26;56;1093;3;56;0.06;42.04;Turkey;Middle East;University of Ankara;1997-2001, 2003-2010, 2014, 2016-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
516;4100151606;Actualites Pharmaceutiques Hospitalieres;journal;17697344;0.114;Q4;3;36;124;273;5;102;0.02;7.58;France;Western Europe;Elsevier Masson s.r.l.;2005-2012;Pharmaceutical Science (Q4)
517;6800153106;International Journal of Essential Oil Therapeutics;journal;19614209;0.114;Q4;13;27;32;794;6;32;0.19;29.41;France;Western Europe;Essential Oil Resource Consultants;2007-2010;"Complementary and Alternative Medicine (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
518;21100301409;Issues in Toxicology;book series;17577179, 17577187;0.114;Q4;16;25;26;3368;2;24;0.08;134.72;United Kingdom;Western Europe;Royal Society of Chemistry;2007-2021;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (Q4); Toxicology (Q4)"
519;22358;U.S. Pharmacist;trade journal;01484818;0.114;Q4;9;161;171;2759;15;161;0.09;17.14;United States;Northern America;Jobson Publishing Corporation;1979, 1990-1996, 2007-2021;"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
520;19430;Adverse Drug Reaction Bulletin;journal;21597774, 00446394;0.113;Q4;7;6;18;177;3;18;0.17;29.5;United States;Northern America;Lippincott Williams and Wilkins Ltd.;1970, 1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
521;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.112;Q4;5;77;262;489;4;254;0.02;6.35;United Kingdom;Western Europe;Samedan Ltd;2004-2019;Pharmaceutical Science (Q4)
522;21083;Pharmaceutical Care Espana (discontinued);journal;11396202;0.112;Q4;9;28;77;477;3;62;0.05;17.04;Spain;Western Europe;Fundacion Pharamaceutical Care Espana;2001-2017;"Pharmacy (Q3); Pharmaceutical Science (Q4); Pharmacology (Q4)"
523;86688;Acta Toxicologica;journal;17316383;0.111;Q4;7;0;53;0;11;48;0.26;0;Poland;Eastern Europe;Nofer Institute of Occupational Medicine;2003-2007;Toxicology (Q4)
524;19400157142;Chiang Mai University Journal of Natural Sciences;journal;16851994;0.111;-;12;0;2;0;0;2;0;0;Thailand;Asiatic Region;Chiang Mai University;2003, 2006, 2009-2021;Multidisciplinary (Q4)
525;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.111;Q4;14;54;124;739;7;123;0.05;13.69;United Kingdom;Western Europe;Taylor and Francis Ltd.;1992, 2004-2013, 2015-2019;"Demography (Q4); Environmental Science (miscellaneous) (Q4); Toxicology (Q4)"
526;21797;Farmaceutisch Tijdschrift voor Belgie;journal;07712367;0.111;Q4;3;26;52;368;3;47;0.08;14.15;Belgium;Western Europe;APB Algemene Pharmaceutische Bond;1978-2013;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
527;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.111;Q4;0;0;0;0;0;0;0;0;Japan;Asiatic Region;Japanese Society of Neuropsychopharmacology;1981-2016;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
528;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;0.111;Q4;47;0;2;0;0;2;0;0;India;Asiatic Region;A and V Publication;1997, 2005, 2011-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
529;25197;Revista de Toxicologia (discontinued);journal;02127113;0.111;Q4;11;12;55;444;6;55;0.09;37;Spain;Western Europe;Asociacion Espanola de Toxicologia;1989-2017, 2020;Toxicology (Q4)
530;19408;Actualites Pharmaceutiques;journal;05153700;0.11;Q4;5;190;538;190;2;421;0;1;Netherlands;Western Europe;Elsevier;1961, 1963, 1996-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
531;19700180757;Advances in Phytomedicine;book series;1572557X;0.11;Q4;13;0;43;0;6;39;0.14;0;Netherlands;Western Europe;Elsevier;2002, 2006;"Drug Discovery (Q4); Plant Science (Q4)"
532;20628;Circular Farmaceutica;journal;00097314;0.11;Q4;3;41;125;350;2;109;0;8.54;Spain;Western Europe;Col-legi de Farmaceutics de la Provincia de Barcelona;1961, 1973-2020;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
533;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.11;Q4;3;88;292;301;1;282;0.01;3.42;United Kingdom;Western Europe;Samedan Ltd;2002-2016;Pharmaceutical Science (Q4)
534;22887;Chinese Journal of Antibiotics;journal;10018689;0.109;Q4;11;202;563;2296;25;556;0.04;11.37;China;Asiatic Region;Editorial Office of Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
535;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;0.109;Q4;9;38;72;174;2;68;0.03;4.58;United Kingdom;Western Europe;Samedan Ltd;2007-2010, 2012-2019;Pharmaceutical Science (Q4)
536;5400152620;American Journal of Pharmacology and Toxicology (discontinued);journal;15574970, 15574962;0.108;Q4;21;23;21;1231;3;21;0.14;53.52;United States;Northern America;Science Publications;2007-2016;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
537;19700175108;Drug Delivery System;journal;18812732, 09135006;0.108;Q4;8;28;109;604;8;109;0.12;21.57;Japan;Asiatic Region;Japan Society of Drug Delivery System;1986, 1988-2021;Pharmaceutical Science (Q4)
538;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.108;Q4;19;132;395;2494;27;386;0.07;18.89;Japan;Asiatic Region;Japanese Pharmacological Society;1944, 1947-1948, 1951-1956, 1958-2021;Pharmacology (Q4)
539;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0.108;Q4;9;12;25;156;3;25;0.07;13;Turkey;Middle East;University of Istanbul;2005, 2007-2008, 2010, 2012, 2015-2016;"Pharmaceutical Science (Q4); Pharmacy (Q4)"
540;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X;0.107;Q4;10;0;0;0;0;0;0;0;Poland;Eastern Europe;Uniwersytet Medyczny w Lublinie;2012-2021;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
541;19700175819;Patient Preference and Adherence;journal;1177889X;0.107;Q4;54;50;18;1598;3;18;0.17;31.96;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2021;"Health Policy (Q4); Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Social Sciences (miscellaneous) (Q4)"
542;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.106;Q4;9;33;94;911;7;72;0.08;27.61;Mexico;Latin America;Asociacion Farmaceutica Mexicana A.C.;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
543;88685;Annual Report of Shionogi Research Laboratory;journal;05598680;0.104;Q4;2;14;5;0;0;5;0;0;Japan;Asiatic Region;Shionogi Co. Ltd;1972-1974, 1987-2009, 2015;Pharmacology (Q4)
544;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;0.104;Q4;5;94;105;1305;5;105;0.05;13.88;China;Asiatic Region;China Pharmaceutical University;2007-2021;"Applied Microbiology and Biotechnology (Q4); Pharmaceutical Science (Q4)"
545;19700188399;Current protocols in toxicology / editorial board, Mahin D. Maines (editor-in-chief) ... [et al.];journal;19349254, 19349262;0.104;Q4;28;22;54;263;8;54;0.19;11.95;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
546;11800154521;ICBPE 2006 - Proceedings of the 2006 International Conference on Biomedical and Pharmaceutical Engineering;conference and proceedings;-;0.104;-;9;0;124;0;6;123;0.05;0;United States;Northern America;;;"Biomedical Engineering; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
547;21077;Pharmaca;journal;00316857;0.104;Q4;5;18;42;153;1;40;0;8.5;Croatia;Eastern Europe;Udruzenje Organizacija Zdravstva Hrvatske;1989-2011;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
548;5800207507;Side Effects of Drugs Annual;book series;03786080;0.103;Q4;6;52;101;3058;3;52;0;58.81;Netherlands;Western Europe;Elsevier;1977-1995, 1997-2005, 2007-2012, 2014-2020;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
549;17744;Anales de la Real Academia Nacional de Medicina;journal;00340634;0.102;Q4;6;37;126;237;3;126;0.02;6.41;Spain;Western Europe;Real Academia de Farmacia;1949-2012, 2014;"Cell Biology (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
550;19982;Asia Pacific Journal of Pharmacology;journal;02179687;0.102;Q4;9;0;10;0;0;9;0;0;Singapore;Asiatic Region;Singapore University Press;1986-1998, 2000-2001, 2003-2004, 2006;Pharmacology (Q4)
551;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.102;Q4;18;24;74;893;1;72;0;37.21;Turkey;Middle East;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-2021;Pharmaceutical Science (Q4)
552;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;18828272, 03881601;0.102;Q4;7;101;139;759;7;137;0.07;7.51;Japan;Asiatic Region;Japanese Society of Clinical Pharmacology and Therapeutics;1970-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
553;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;0.102;Q4;6;0;9;0;1;9;0.11;0;Nigeria;Africa;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009, 2015-2016;Pharmacology (Q4)
554;130150;Advances in Pharmacy;journal;15323862;0.101;Q4;2;0;25;0;0;16;0;0;United States;Northern America;Facts and Comparisons;2005;Pharmaceutical Science (Q4)
555;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074, 09728066;0.101;Q4;11;10;31;61;3;22;0.05;6.1;India;Asiatic Region;Anil Aggrawal;2000-2020;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
556;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;0.101;Q4;8;18;26;665;0;24;0;36.94;Venezuela;Latin America;Sociedad Latinoamericana de Hipertension;2007-2013, 2015-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
557;9100153105;Current Topics in Pharmacology;journal;09724559;0.101;Q4;6;16;36;1219;1;36;0.03;76.19;India;Asiatic Region;Research Trends;2006-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
558;4700152278;Drugs in Context;journal;17404398, 17451981;0.101;Q4;26;20;59;710;1;44;0.02;35.5;United Kingdom;Western Europe;BioExcel Publishing Ltd.;2006-2008, 2012-2021;"Molecular Medicine (Q4); Pharmacology (Q4)"
559;144718;Enhancer - Biotherapy of Cancer;journal;15720004;0.101;Q4;0;0;43;0;0;21;0;0;Netherlands;Western Europe;;2005-2006;"Cancer Research (Q4); Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Oncology (Q4)"
560;21867;Geneesmiddelenbulletin;journal;03044629;0.101;Q4;7;65;214;235;4;31;0.02;3.62;Netherlands;Western Europe;Stichting Geneesmiddelenbulletin;1973-2021;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
561;17700156431;Handbook of Analytical Separations;book series;15677192;0.101;Q4;12;32;0;4856;0;0;0;151.75;Netherlands;Western Europe;Elsevier;2000-2001, 2003-2004, 2008, 2020;"Analytical Chemistry (Q4); Environmental Chemistry (Q4); Pathology and Forensic Medicine (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
562;21932;Hindustan Antibiotics Bulletin;journal;00181935;0.101;Q4;9;0;16;0;0;16;0;0;India;Asiatic Region;Hindustan Antibiotics Ltd.;1960-1961, 1965-2000, 2002-2003, 2005, 2007, 2009;Pharmacology (Q4)
563;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.101;Q4;10;12;31;155;0;29;0;12.92;Netherlands;Western Europe;Brill Academic Publishers;1995, 1997, 2001, 2004-2006, 2008-2011, 2013-2021;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
564;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0.101;Q4;7;281;802;2810;22;802;0.03;10;China;Asiatic Region;Jilin University Press;2005-2021;Pharmacology (Q4)
565;21243;Pharmacy Times;trade journal;00030627;0.101;Q4;8;205;256;497;10;220;0.04;2.42;United States;Northern America;Intellisphere LLC;1977-1987, 2007-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
566;89630;Psychopharmakotherapie, Supplement;journal;09465146;0.101;Q4;2;7;40;121;0;29;0;17.29;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;1997-1999, 2004-2005, 2007-2008;"Pharmacology (Q4); Psychiatry and Mental Health (Q4)"
567;145000;Signal;journal;14719967;0.101;Q4;1;0;34;0;1;20;0;0;United Kingdom;Western Europe;Adis International Ltd;2005-2007;"Drug Discovery (Q4); Oncology (Q4); Pharmacology (medical) (Q4)"
568;10300153375;Taiwan Pharmaceutical Journal;journal;10161015;0.101;Q4;5;0;25;0;0;25;0;0;Taiwan;Asiatic Region;Pharmaceutical Society of Republic of China;2007, 2009;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
569;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790, 21684804;0.101;Q4;46;122;238;2100;143;229;0.63;17.21;United States;Northern America;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-2021;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4)"
570;9500153932;Ciencia y Tecnologia Pharmaceutica;journal;15753409;0.1;Q4;6;0;55;0;1;45;0;0;Spain;Western Europe;Fundacion Alimentacion Saludable;1996-2007;Pharmacology (Q4)
571;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.1;Q4;34;22;49;539;4;49;0;24.5;United States;Northern America;"John Wiley &amp; Sons Inc.";2001-2020;"Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
572;21238;Drug Topics;journal;19378157, 00126616;0.1;Q4;8;305;1296;0;5;1025;0;0;United States;Northern America;Advanstar Communications Inc.;1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
573;5100154302;European Biotechnology Science and Industry News;journal;16188276;0.1;Q4;2;69;162;43;0;151;0;0.62;Germany;Western Europe;Biocom AG;2006-2013;"Biotechnology (Q4); Drug Discovery (Q4)"
574;15680;Giornale di Neuropsicofarmacologia;journal;19711387, 03919048;0.1;Q4;1;18;54;119;0;47;0;6.61;Italy;Western Europe;CIC Edizioni Internazionali s.r.l.;1996-2008;"Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
575;13637;Manufacturing Chemist;trade journal;02624230;0.1;Q4;6;85;89;165;0;78;0;1.94;United Kingdom;Western Europe;Wilmington Publishing;1981-1984, 1986, 1989, 1996-2001, 2006-2021;Pharmaceutical Science (Q4)
576;21823;Pharmacia;journal;04280296;0.1;Q4;16;12;107;161;4;107;0.06;13.42;Bulgaria;Eastern Europe;Pensoft Publishers;1945, 1954-1955, 1987-1991, 1997-2021;"Pharmaceutical Science (Q4); Pharmacology (medical) (Q4); Pharmacy (Q4)"
577;5000158120;Pharmacy News;journal;1448207X;0.1;Q4;1;325;398;24;0;138;0;0.07;United Kingdom;Western Europe;Reed Business Publishing;2006-2009;"Pharmaceutical Science (Q4); Pharmacology (nursing) (Q4)"
578;5200152604;Pharma Times;journal;00316849;0.1;Q4;12;62;96;282;1;70;0.01;4.55;India;Asiatic Region;Indian Pharmaceutical Association;2006-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
579;72755;Phytomedica;journal;09723293;0.1;Q4;4;14;49;108;0;49;0;7.71;India;Asiatic Region;Society of Phytomedica;1999-2008;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
580;19700175149;African Journal Biomedical Research;journal;11195096;;-;17;47;0;995;0;0;0;21.17;Nigeria;Africa;Ibadan Biomedical Communications Group;2008, 2010-2021;"Medicine (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
581;19700174969;Archives of Drug Information;journal;17535174;;-;11;14;0;368;0;0;0;26.29;United States;Northern America;"John Wiley &amp; Sons Inc.";2008-2011;"Complementary and Alternative Medicine; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
582;19700174886;Arzneimitteltherapie;journal;07236913;;-;6;162;0;1153;0;0;0;7.12;Germany;Western Europe;Wissenschaftliche Verlagsgesellschaft Stuttgart;2008-2021;"Pharmacology (medical); Pharmacology (nursing); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
583;10900153302;Biomarker Insights;journal;11772719;;-;35;35;0;2221;0;0;0;63.46;New Zealand;Pacific Region;Libertas Academica Ltd.;2008-2021;"Biochemistry (medical); Molecular Medicine; Pharmacology"
584;11300153402;Biomarkers in Medicine;journal;17520363, 17520371;;-;49;50;0;3046;0;0;0;60.92;United Kingdom;Western Europe;Future Medicine Ltd.;2008-2021;"Biochemistry (medical); Clinical Biochemistry; Drug Discovery"
585;18800156730;Biomolecules and Therapeutics;journal;19769148, 20054483;;-;44;65;0;1800;0;0;0;27.69;South Korea;Asiatic Region;Korean Society of Applied Pharmacology;2008-2021;"Biochemistry; Drug Discovery; Molecular Medicine; Pharmacology"
586;19200156945;Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas;journal;07177917;;-;22;40;0;1635;0;0;0;40.88;Chile;Latin America;MS-Editions;2008-2021;"Complementary and Alternative Medicine; Drug Discovery; Pharmacology; Plant Science"
587;21100204921;Bulletin of Pharmaceutical Sciences;journal;11100052;;-;8;25;0;700;0;0;0;28;Egypt;Africa/Middle East;Faculty of Pharmacy, Assiut University;2008-2014, 2018-2021;"Pharmaceutical Science; Pharmacology"
588;11900154314;Cardiovascular Therapeutics;journal;17555914, 17555922;;-;48;32;0;1922;0;0;0;60.06;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Cardiology and Cardiovascular Medicine; Medicine (miscellaneous); Pharmacology; Pharmacology (medical)"
589;19700174892;Chinese Journal of Cancer Biotherapy;journal;1007385X;;-;5;129;0;2495;0;0;0;19.34;China;Asiatic Region;Editorial office of Chinese Journal of Cancer Biotherapy;2008-2011, 2013-2016, 2018-2022;"Cancer Research; Molecular Medicine; Pharmacology"
590;19700174922;Chinese Journal of New Drugs;journal;10033734;;-;12;565;0;6700;0;0;0;11.86;China;Asiatic Region;Chinese Journal of New Drugs Co. Ltd.;2008-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
591;19700174918;Clinical and Translational Science;journal;17528062, 17528054;;-;48;61;0;1509;0;0;0;24.74;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Medicine (miscellaneous); Neuroscience (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
592;11700154316;CNS Neuroscience and Therapeutics;journal;17555949, 17555930;;-;75;31;0;2582;0;0;0;83.29;United Kingdom;Western Europe;Wiley-Blackwell Publishing Ltd;2008-2021;"Pharmacology; Pharmacology (medical); Physiology (medical); Psychiatry and Mental Health"
593;19600166302;Current Molecular Pharmacology;journal;18744702;;-;42;23;0;2979;0;0;0;129.52;United Arab Emirates;Middle East;Bentham Science Publishers;2008-2021;"Drug Discovery; Molecular Medicine; Pharmacology"
594;17700156434;Current Pharmacogenomics and Personalized Medicine;journal;18756913, 18756921;;-;19;26;0;2826;0;0;0;108.69;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2018, 2020;"Genetics; Genetics (clinical); Molecular Biology; Molecular Medicine; Pharmacology"
595;21101055116;Current Reviews in Clinical and Experimental Pharmacology;journal;27724328, 27724336;;-;43;24;51;1878;49;51;0.96;78.25;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
596;19300156901;Dose-Response;journal;15593258;;-;41;21;0;1262;0;0;0;60.1;United States;Northern America;International Dose-Response Society;2008-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Public Health, Environmental and Occupational Health; Toxicology"
597;19700175230;Drug Design, Development and Therapy;journal;11778881;;-;71;29;1;1680;0;0;0;57.93;New Zealand;Pacific Region;Dove Medical Press Ltd.;2007-2021;"Drug Discovery; Pharmaceutical Science; Pharmacology"
598;19700174889;Drug Target Insights;journal;11773928;;-;13;14;0;736;0;0;0;52.57;Italy;Western Europe;AboutScience Srl;2008-2009, 2011-2020;"Clinical Biochemistry; Medicine (miscellaneous); Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
599;19200156912;EJHP Practice;trade journal;20303769, 17819989;;-;6;25;0;126;0;0;0;5.04;Belgium;Western Europe;Pharma Publishing and Media Europe;2008-2011;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
600;21100938253;Environmental Pollutants and Bioavailability;journal;26395940, 26395932;;-;33;23;47;801;46;47;0.74;34.83;United Kingdom;Western Europe;Taylor and Francis Ltd.;2019-2021;"Chemical Health and Safety; Health, Toxicology and Mutagenesis; Toxicology"
601;19700174992;European Journal of Oncology Pharmacy;journal;17833914;;-;4;17;0;77;0;0;0;4.53;Belgium;Western Europe;Pharma Publishing and Media Europe;2008-2015, 2017-2019;"Oncology; Pharmacology"
602;10300153301;Expert Review of Clinical Pharmacology;journal;17512433, 17512441;;-;46;71;0;5038;0;0;0;70.96;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Medicine (miscellaneous); Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
603;21810;Farmacia;journal;00148237;;-;27;84;0;938;0;0;0;11.17;Romania;Eastern Europe;Romanian Society for Pharmaceutical Sciences;1945-1946, 1973-1987, 2003, 2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
604;18500157900;Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment;journal;19440057, 19440049;;-;80;173;0;5865;0;0;0;33.9;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Chemistry (miscellaneous); Food Science; Health, Toxicology and Mutagenesis; Medicine (miscellaneous); Public Health, Environmental and Occupational Health; Toxicology"
605;19400157146;Food Additives and Contaminants: Part B Surveillance;journal;19393210, 19393229;;-;32;22;0;622;0;0;0;28.27;United Kingdom;Western Europe;Taylor and Francis Ltd.;2008-2021;"Food Science; Public Health, Environmental and Occupational Health; Toxicology"
606;11200153304;Future HIV Therapy;journal;17469600, 17469619;;-;8;57;0;3017;0;0;0;52.93;United Kingdom;Western Europe;Future Medicine Ltd.;2008-2009;"Drug Discovery; Infectious Diseases; Pharmacology; Pharmacology (medical); Virology"
607;19700174970;Hacettepe University Journal of the Faculty of Pharmacy;journal;13000608;;-;7;12;0;559;0;0;0;46.58;Turkey;Middle East;Hacettepe University, Faculty of Pharmacy;2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
608;19200156909;Indian Journal of Pharmaceutical Education and Research;journal;00195464;;-;22;71;0;1197;0;0;0;16.86;India;Asiatic Region;Association of Pharmaceutical Teachers of India;2008-2021;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
609;19700177407;Interdisciplinary Toxicology;journal;13379569, 13376853;;-;34;26;0;757;0;0;0;29.12;Slovakia;Eastern Europe;Slovak Toxicology Society SETOX;2008-2020;"Health, Toxicology and Mutagenesis; Pharmacology; Toxicology"
610;19600161802;International Journal of Computational Biology and Drug Design;journal;17560764, 17560756;;-;14;30;0;683;0;0;0;22.77;United Kingdom;Western Europe;Inderscience Enterprises Ltd;2008-2021;"Computer Science Applications; Drug Discovery"
611;19700174628;Iranian Journal of Basic Medical Sciences;journal;20083874, 20083866;;-;44;31;16;1028;1;16;0.06;33.16;Iran;Middle East;Mashhad University of Medical Sciences;2007-2021;"Biochemistry; Biophysics; Clinical Biochemistry; Drug Discovery; Immunology and Microbiology (miscellaneous) "
612;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;;-;48;44;119;1028;28;108;0.16;23.36;Iran;Middle East;Iranian Journal of Pharmaceutical Research;2002-2021;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
613;14500154702;Journal of Cardiovascular Translational Research;journal;19375395, 19375387;;-;53;62;0;1486;0;0;0;23.97;United States;Northern America;Springer New York;2008-2021;"Cardiology and Cardiovascular Medicine; Genetics; Genetics (clinical); Molecular Medicine; Pharmaceutical Science"
614;27767;Journal of Forensic Medicine and Toxicology;journal;09711929;;-;18;25;61;314;4;60;0.07;12.56;India;Asiatic Region;;1997-2020;"Pathology and Forensic Medicine; Toxicology"
615;11200153306;Journal of Pharmacology and Toxicology (discontinued);journal;1816496X, 2152100X;;-;18;57;0;1460;0;0;0;25.61;United States;Northern America;Academic Journals Inc.;2008-2017;Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
616;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;;-;26;146;335;3799;101;335;0.26;26.02;Argentina;Latin America;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-2021;"Drug Discovery; Pharmaceutical Science"
617;19700182629;Methods in Pharmacology and Toxicology;book series;15572153, 19406053;;-;10;22;0;1742;0;0;0;79.18;United States;Northern America;Humana Press;2008, 2012, 2014-2021;"Molecular Medicine; Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
618;11900154394;Oriental Journal of Chemistry (discontinued);journal;0970020X, 22315039;;-;27;211;0;3380;0;0;0;16.02;India;Asiatic Region;Bhopal, S.A. Iqbal;1989, 2008-2018, 2021;"Biochemistry; Chemistry (miscellaneous); Drug Discovery; Environmental Chemistry"
619;19700174891;Perspectives in Medicinal Chemistry;journal;11773910, 1177391X;;-;16;7;0;666;0;0;0;95.14;New Zealand;Pacific Region;Libertas Academica Ltd.;2008-2011, 2014-2016;"Drug Discovery; Pharmaceutical Science; Pharmacology; Pharmacology (medical)"
620;12100156730;Pharmaceutische Weekblad Wetenschappelijk Platform;journal;18738982;;-;2;10;0;131;0;0;0;13.1;Netherlands;Western Europe;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);2008, 2013-2015;"Pharmacology; Pharmacology (medical)"
621;19200156706;Pharmacognosy Magazine (discontinued);journal;09731296, 09764062;;-;42;75;0;1654;0;0;0;22.05;India;Asiatic Region;Wolters Kluwer Medknow Publications;2008-2018, 2020-2021;"Drug Discovery; Pharmaceutical Science"
622;19700174966;Pharmakeftiki;journal;22413081, 11054999;;-;5;16;0;515;0;0;0;32.19;Greece;Western Europe;Zita Medical Managent;2008-2010, 2012-2021;"Pharmaceutical Science; Pharmacology"
623;19400157518;Rasayan Journal of Chemistry;journal;09760083, 09741496;;-;24;128;0;2826;0;0;0;22.08;India;Asiatic Region;Rasayan Journal;2008-2021;"Biochemistry; Chemical Engineering (miscellaneous); Chemistry (miscellaneous); Energy (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
624;21101055117;Recent Advances in Anti-Infective Drug Discovery;journal;27724352, 27724344;;-;33;22;52;1985;67;52;1.29;90.23;United Arab Emirates;Middle East;Bentham Science Publishers;2021;"Drug Discovery; Infectious Diseases; Pharmacology (medical)"
625;11400153330;Recent Patents on Endocrine, Metabolic and Immune Drug Discovery;journal;18722148, 22123334;;-;25;25;0;2328;0;0;0;93.12;United Arab Emirates;Middle East;Bentham Science Publishers B.V.;2008-2017;"Biochemistry (medical); Drug Discovery; Endocrinology, Diabetes and Metabolism; Immunology and Allergy; Medicine (miscellaneous)"
626;19700175031;Research Journal of Pharmacology (discontinued);journal;19936019, 18159362;;-;9;12;0;222;0;0;0;18.5;Pakistan;Asiatic Region;Medwell Publishing;2008-2014, 2016;"Pharmacology (medical); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
627;19700174913;Therapeutic Advances in Neurological Disorders;journal;17562864, 17562856;;-;56;18;0;1083;0;0;0;60.17;United Kingdom;Western Europe;SAGE Publications Ltd;2008-2021;"Neurology; Neurology (clinical); Pharmacology"
628;21100197929;Toxicological Research;journal;19768257, 22342753;;-;35;42;0;1552;0;0;0;36.95;South Korea;Asiatic Region;Koreal Association of Medical Journal Editors;2008-2021;"Health, Toxicology and Mutagenesis; Toxicology"
629;19700175137;Trends in Medical Research (discontinued);journal;18193587, 21516065;;-;10;11;0;373;0;0;0;33.91;United States;Northern America;Academic Journals Inc.;2008-2016, 2020-2021;"Biochemistry, Genetics and Molecular Biology (miscellaneous); Medicine (miscellaneous); Pharmacology, Toxicology and Pharmaceutics (miscellaneous)"
